Fill - Free fillable INVITATIONTO BID (South Africa Department of Health) PDF form

INVITATIONTO

BID



HP06-2021SVP



SUPPLY AND DELIVERY OF SMALL

VOLUME PARENTERALS AND INSULIN

DEVICES TO THE DEPARTMENT OF

HEALTH FOR THE PERIOD

1 MAY 2021 TO 30 APRIL 2023

BID VALIDITY PERIOD: 120 DAYS

No Briefing Session will be held

All tender related enquiries can be mailed to

tenders@health.gov.za

PLEASE NOTE: AN ERRATUM WILL BE PUBLISHED TO AMEND THE CLOSING DATE TO

28 SEPTEMBER 2020

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 1

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 2

CONTACT PERSONS AT THE NATIONAL DEPARTMENT OF HEALTH

Please direct any queries relating to the bidding process to tenders@health.gov.za



BID DOCUMENTS FOR COMPLETION AND SUBMISSION

All bid documents listed below must be sorted, filed and submitted in the exact compilation

sequence as indicated below and in Annexure A attached.

Submission of bid documents is mandatory, unless it's not applicable and indicated as such

in the "N/A" column in the Bid Document Check List.

All bid documents must be signed.

Bidders not complying to any of the requirements will be deemed to be non-responsive and

will not be considered for evaluation.

 Covering Letter i.e. limited stock availability of any item offered, non-compliance;

 Status relating to TAX, B-BBEE, License to Manufacture, Certificates etc. Bid Signature;

 Resolution/Authority to sign bid;

 Bid/File Index;

 PBD 4.1: Contact Details of Bidder;

 SBD 1: Invitation to bid;

 Tax Clearance Pin Issued;

 CSD Registration report - A certified copy of latest and complete report. Note: CSD

summary report will not be accepted;

 SBD 4: Declaration of interest;

 PBD9: Directors: Categorisation by race, gender and disability;

 SBD5: The National Industrial Participation Programme;

 SBD 6(1): Preference Points Claimed (B-BBEE);

 Valid B-BBEE certificate (certified copy) or Sworn Affidavit to claim preference points;

 SBD 8: Declaration of Past SCM Practices;

 SBD 9: Certificate of Independent Bid Determination;

 PBD1: Authorisation Declaration Note: Non-compliance to submission of a valid

authorisation declaration, where applicable, may invalidate the bid;

 PBD 1.1: List of products offered sourced from third party;

 PBD 1.2: Unconditional written undertaking from the third party;

 PBD5: Good Manufacturing Practice (GMP). Declaration of compliance;

 PBD 8: Special Requirements and Conditions of Contact. Declaration of compliance;

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 3

 CIPC/CIPRO or proof of ownership/shareholding. Certified copies of registration

certificates;

 Proof of company cedings, mergers and name changes;

 Certified copy of Licence to manufacture or import (in the name of the bidder),

including all annexures;

 Certified copy of Licence to manufacture medicines, including all annexures for local

manufacturing sites as listed on the MRC of the bidder (applicant);

 Certified copies of Medicine Registration Certificates (MRC) with all the associated

conditions of registration (Annexure). Note: All MRC's must be marked by the

bidder with the relevant item number and be sorted and filed in numerical order;

 Original Package Insert (PI) or document detailing professional information approved by

the Medicines Control Council (MCC) or the South African Health Products Regulatory

Authority (SAHPRA) for each product offered. Note: All PI`s must be marked with the

relevant item number and be sorted and filed/submitted in numerical

 order;

 Proof of sample submission;

 Bidder`s item list (List of products offered); and

 Signed Excel Bid Response Pricing Schedule (All prices must be submitted in 2 (two)

decimals). If the Excel Bid Response Pricing Schedule is not signed in the space

provided, the bid will not be considered for evaluation.

COMPLETION OF DOCUMENTS AND BID SUBMISSION

Bidders are required to submit three sets of bid documents according to the instructions

below. All three sets must be submitted not later than the closing date and time. Set 2 and

Set 3 must be included on a CD with Set 1 submitted in a sealed package. The full name

and address of the bidder, including the return address, the bid number and the closing

date must be clearly indicated on the package. All fields must be completed. Where

information requested is not relevant this should be indicated with N/A.

Set 1: Hard copy (legally binding bid documents)

Bidders must complete all SBD, PBD and Bid Response forms in black ink, typed. Where

no electronic entry field is provided bidders must complete the forms in black ink,

handwritten in capital letters. The signed hard copy of the bid document will serve as the

legal bid document.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 4

Bidders must submit their complete bid in hard copy format (paper document). The Chief

Executive Officer, Chief Financial Officer, or authorised designee of the entity submitting the

bid must sign the official signature pages. All pages in the complete bid document must be

initialed by same with black ink. The use of correction fluid is not acceptable. Any change/s

must be clearly indicated and initialed.

As the National Department of Health complies with the regulations made under the

Disaster Management Act, 2002, published in the Gazette 18 March 2020 no briefing

session of public bid opening will be held. However, Bidders must still ensure that bids are

delivered on time to the correct address and deposited in the Tender Box. Late bids will not

be accepted for consideration.

Bidders must refrain from using binding methods like coil, comb, wire velobind,

screw binding etc. It is requested that bidders pre-punch two holes on the left hand

side of bid documents suitable for filing in a two hole lever arch file. Bid documents

should be tied in parcels using string or rope that can be easily untied for filing

purposes.

Set 2: PDF of Hard Copy, signed legal documents. (i.e. pdf of Set 1)

Bidders must submit a PDF version of the entire signed hardcopy bid, including all

certificates and documents requested.

Set 3: Electronic version of bid documents

Bidders must submit the electronic versions (editable pdf) of all SBD and PBD documents,

Bid Response Document and other relevant spreadsheets in Excel (not pdf).

All three sets of information must be submitted in order for the bid to be evaluated.

Bidders must ensure that the price quoted for a product (line item) on the Excel Bid

Response Document is for the unit pack specified. No conversion factors will be applied.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 5

INVITATION TO BID

SBD 1

YOU ARE HEREBY INVITED TO BID FOR REQUIREMENTS OF THE NATIONAL

DEPARTMENT OF HEALTH

BID NUMBER: HP06-2021SVP

CLOSING DATE: 24 AUGUST 2020 CLOSING TIME:11:00

DESCRIPTION Supply and Delivery of Small Volume Parenterals and Insulin Devices to the

Department of Health for the period 1 May 2021 to 30 April 2023

Bid documents must be addressed as follows and delivered before the closing date and time:

Addressed to:

The Director-General: Health

Civitas Building

C/o Struben and Thabo Sehume Streets,

Pretoria

Delivered to:

Pharmaceutical Tender Box

Reception Area

National Department of Health

Civitas Building,

C/o Struben and Thabo Sehume Streets,

Pretoria

Bidders should ensure that bids are delivered on time to the correct address and deposited

in the Pharmaceutical Tender Box. Late bids will not be accepted for consideration

The Pharmaceutical Tender Box is generally accessible during extended working hours.

See below for map locating Civitas Building within Pretoria Central Business District.

ALL BIDS MUST BE SUBMITTED ON THE OFFICIAL FORMS

This competitive bidding process is subject to the Preferential Procurement Policy Framework Act

and the Preferential Procurement Regulations, 2011, the General Conditions of Contract (GCC)

and, if applicable, any other Special Requirements and Conditions of Contract.



2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 6

SBD1

1

PART A

INVITATION TO BID

YOU ARE HEREBY INVITED TO BID FOR REQUIREMENTS OF THE NATIONAL DEPARTMENT OF HEALTH

BID NUMBER: HP06-2021SVP CLOSING DATE: 24 AUGUST 2020 CLOSING TIME: 11:00

DESCRIPTION SUPPLY AND DELIVERY OF SMALL VOLUME PARENTERALS AND INSULIN DEVICES TO THE DEPARTMENT OF HEALTH

FOR THE PERIOD 1 MAY 2021 TO 30 APRIL 2023

BID RESPONSE DOCUMENTS MAY BE DEPOSITED IN THE BID BOX SITUATED AT C/O STRUBEN AND THABO SEHUME STREETS

PHARMACEUTICAL TENDER BOX

RECEPTION AREA

NATIONAL DEPARTMENT OF HEALTH

CIVITAS BUILDING

BIDDING PROCEDURE ENQUIRIES MAY BE DIRECTED TO TECHNICAL ENQUIRIES MAY BE DIRECTED TO:

CONTACT PERSON CONTACT PERSON

TELEPHONE NUMBER TELEPHONE NUMBER

FACSIMILE NUMBER FACSIMILE NUMBER

E-MAIL ADDRESS TENDERS@HEALTH.GOV.ZA E-MAIL ADDRESS TENDERS@HEALTH.GOV.ZA

SUPPLIER INFORMATION

NAME OF BIDDER

POSTAL ADDRESS

STREET ADDRESS

TELEPHONE NUMBER CODE NUMBER

CELLPHONE NUMBER

FACSIMILE NUMBER CODE NUMBER

E-MAIL ADDRESS

VAT REGISTRATION

NUMBER

SUPPLIER

COMPLIANCE

STATUS

TAX

COMPLIANCE

SYSTEM PIN:

OR

CENTRAL

SUPPLIER

DATABASE

No: MAAA

B-BBEE STATUS

LEVEL VERIFICATION

CERTIFICATE

TICK APPLICABLE BOX]

Yes No

B-BBEE STATUS LEVEL SWORN

AFFIDAVIT

[TICK APPLICABLE BOX]

Yes No

[A B-BBEE STATUS LEVEL VERIFICATION CERTIFICATE/ SWORN AFFIDAVIT (FOR EMES & QSEs) MUST BE SUBMITTED IN

ORDER TO QUALIFY FOR PREFERENCE POINTS FOR B-BBEE]

ARE YOU THE

ACCREDITED

REPRESENTATIVE IN

SOUTH AFRICA FOR

THE GOODS

/SERVICES /WORKS

OFFERED?

Yes No

[IF YES ENCLOSE PROOF]

ARE YOU A FOREIGN BASED

SUPPLIER FOR THE GOODS

/SERVICES /WORKS OFFERED?

Yes No

[IF YES, ANSWER THE

QUESTIONNAIRE BELOW ]

QUESTIONNAIRE TO BIDDING FOREIGN SUPPLIERS

IS THE ENTITY A RESIDENT OF THE REPUBLIC OF SOUTH AFRICA (RSA)? YES NO

DOES THE ENTITY HAVE A BRANCH IN THE RSA?

YES NO

DOES THE ENTITY HAVE A PERMANENT ESTABLISHMENT IN THE RSA?

YES NO

DOES THE ENTITY HAVE ANY SOURCE OF INCOME IN THE RSA?

YES NO

IS THE ENTITY LIABLE IN THE RSA FOR ANY FORM OF TAXATION?

YES NO

IF THE ANSWER IS “NO” TO ALL OF THE ABOVE, THEN IT IS NOT A REQUIREMENT TO REGISTER FOR A TAX COMPLIANCE STATUS

SYSTEM PIN CODE FROM THE SOUTH AFRICAN REVENUE SERVICE (SARS) AND IF NOT REGISTER AS PER 2.3 BELOW.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 7

SBD1

2

PART B

TERMS AND CONDITIONS FOR BIDDING

1. BID SUBMISSION:

1.1. BIDS MUST BE DELIVERED BY THE STIPULATED TIME TO THE CORRECT ADDRESS. LATE BIDS WILL NOT BE ACCEPTED FOR

CONSIDERATION.

1.2. ALL BIDS MUST BE SUBMITTED ON THE OFFICIAL FORMS PROVIDED–(NOT TO BE RE-TYPED) OR IN THE MANNER PRESCRIBED IN

THE BID DOCUMENT.

1.3. THIS BID IS SUBJECT TO THE PREFERENTIAL PROCUREMENT POLICY FRAMEWORK ACT, 2000 AND THE PREFERENTIAL

PROCUREMENT REGULATIONS, 2017, THE GENERAL CONDITIONS OF CONTRACT (GCC) AND, IF APPLICABLE, ANY OTHER

SPECIAL CONDITIONS OF CONTRACT.

1.4. THE SUCCESSFUL BIDDER WILL BE REQUIRED TO FILL IN AND SIGN A WRITTEN CONTRACT FORM (SBD7).

2. TAX COMPLIANCE REQUIREMENTS

2.1 BIDDERS MUST ENSURE COMPLIANCE WITH THEIR TAX OBLIGATIONS.

2.2 BIDDERS ARE REQUIRED TO SUBMIT THEIR UNIQUE PERSONAL IDENTIFICATION NUMBER (PIN) ISSUED BY SARS TO ENABLE THE

ORGAN OF STATE TO VERIFY THE TAXPAYER’S PROFILE AND TAX STATUS.

2.3 APPLICATION FOR TAX COMPLIANCE STATUS (TCS) PIN MAY BE MADE VIA E-FILING THROUGH THE SARS WEBSITE

WWW.SARS.GOV.ZA.

2.4 BIDDERS MAY ALSO SUBMIT A PRINTED TCS CERTIFICATE TOGETHER WITH THE BID.

2.5 IN BIDS WHERE CONSORTIA / JOINT VENTURES / SUB-CONTRACTORS ARE INVOLVED, EACH PARTY MUST SUBMIT A SEPARATE

TCS CERTIFICATE / PIN / CSD NUMBER.

2.6 WHERE NO TCS PIN IS AVAILABLE BUT THE BIDDER IS REGISTERED ON THE CENTRAL SUPPLIER DATABASE (CSD), A CSD

NUMBER MUST BE PROVIDED.

2.7 NO BIDS WILL BE CONSIDERED FROM PERSONS IN THE SERVICE OF THE STATE, COMPANIES WITH DIRECTORS WHO ARE

PERSONS IN THE SERVICE OF THE STATE, OR CLOSE CORPORATIONS WITH MEMBERS PERSONS IN THE SERVICE OF THE

STATE.”

NB: FAILURE TO PROVIDE / OR COMPLY WITH ANY OF THE ABOVE PARTICULARS MAY RENDER THE BID INVALID.

SIGNATURE OF BIDDER: ……………………………………………

CAPACITY UNDER WHICH THIS BID IS SIGNED: ……………………………………………

(Proof of authority must be submitted e.g. company resolution)

DATE: …………………………………………...

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 8

PBD4.1

Private Bag X828, PRETORIA, 0001. Civitas Building Cnr Thabo Sehume & Struben Streets, PRETORIA 0001

Directorate: Access to Affordable Medicines Tel: (012) 395 8130 Fax: (012) 395 8823/4

CO

NTRA

CT

NU

M

B

ER

:

SUPPLIER DETAILS:

Note that Provincial Departments of Health will require separate registration of suppliers on their Databases

& could request completion of Province-specific documents.

If a contract is awarded, full detail for supplier registration or verification will be requested.

Should any of the detail provided below change, please advise the National Department of Health

immediately in writing with detail of such change(s).

CONTACT DETAIL

1. Supplier Registered Name

Legal entity / corresponding

with banking detail

2. Contact person regarding contract enquiries (to be printed on contract cover)

Name &

Surname

e-mail

Telephone

Fax

Cell

Other

3. Contact regarding orders

Address for posting of orders

Fax

Tel

(confirmation)

EDI

Order

enquiries

Name & surname:

Tel

e-mail

4.

National

key

Account

Manager (or Tender Manager)

Name

e-mail

Telephone

Cell

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 9

HP06-2021SVP

SIGNATURE FOR PBD4.1

I / we, the undersigned, herewith certify that all of the above information is correct at the time of

completion. I/ we furthermore certify that I / we have the appropriate authority to furnish the above-

mentioned information on behalf of our employer.

Name:

Signature

Designation:

Date

Name:

Signature

Designation:

Date

PBD 4.1

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 10

SBD 6.1

PREFERENCE POINTS CLAIM FORM IN TERMS OF THE PREFERENTIAL

PROCUREMENT REGULATIONS 2017

This preference form must form part of all bids invited. It contains general information and

serves as a claim form for preference points for Broad-Based Black Economic Empowerment

(B-BBEE) Status Level of Contribution

NB: BEFORE COMPLETING THIS FORM, BIDDERS MUST STUDY THE GENERAL

CONDITIONS, DEFINITIONS AND DIRECTIVES APPLICABLE IN RESPECT OF B-

BBEE, AS PRESCRIBED IN THE PREFERENTIAL PROCUREMENT

REGULATIONS, 2017.

1. GENERAL CONDITIONS

1.1 The following preference point systems are applicable to all bids:

- the 80/20 system for requirements with a Rand value of up to R50 000 000 (all

applicable taxes included); and

- the 90/10 system for requirements with a Rand value above R50 000 000 (all

applicable taxes included).

1.2

a) The value of this bid is estimated to exceed R50 000 000 (all applicable taxes included)

and therefore the 90/10 preference point system shall be applicable; or

b) Either the 80/20 or 90/10 preference point system will be applicable to this tender

(delete whichever is not applicable for this tender).

1.3 Points for this bid shall be awarded for:

(a) Price; and

(b) B-BBEE Status Level of Contributor.

1.4 The maximum points for this bid are allocated as follows:

POINTS

PRICE

90

B-BBEE STATUS LEVEL OF CONTRIBUTOR

10

Total points for Price and B-BBEE must not

exceed

100

1.5 Failure on the part of a bidder to submit proof of B-BBEE Status level of contributor

together with the bid, will be interpreted to mean that preference points for B-BBEE status

level of contribution are not claimed.

1.6 The purchaser reserves the right to require of a bidder, either before a bid is adjudicated

or at any time subsequently, to substantiate any claim in regard to preferences, in any

manner required by the purchaser.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 11

Page 2 of 5

2

2. DEFINITIONS

(a) “B-BBEE” means broad-based black economic empowerment as defined in section

1 of the Broad-Based Black Economic Empowerment Act;

(b) “B-BBEE status level of contributor” means the B-BBEE status of an entity in terms

of a code of good practice on black economic empowerment, issued in terms of

section 9(1) of the Broad-Based Black Economic Empowerment Act;

(c) “bid” means a written offer in a prescribed or stipulated form in response to an

invitation by an organ of state for the provision of goods or services, through price

quotations, advertised competitive bidding processes or proposals;

(d) “Broad-Based Black Economic Empowerment Act” means the Broad-Based

Black Economic Empowerment Act, 2003 (Act No. 53 of 2003);

(e) “EME” means an Exempted Micro Enterprise in terms of a code of good practice on

black economic empowerment issued in terms of section 9 (1) of the Broad-Based

Black Economic Empowerment Act;

(f) “functionality” means the ability of a tenderer to provide goods or services in

accordance with specifications as set out in the tender documents.

(g) “prices” includes all applicable taxes less all unconditional discounts;

(h) “proof of B-BBEE status level of contributor” means:

1) B-BBEE Status level certificate issued by an authorized body or person;

2) A sworn affidavit as prescribed by the B-BBEE Codes of Good Practice;

3) Any other requirement prescribed in terms of the B-BBEE Act;

(i) “QSE” means a qualifying small business enterprise in terms of a code of good

practice on black economic empowerment issued in terms of section 9 (1) of the

Broad-Based Black Economic Empowerment Act;

(j) “rand value” means the total estimated value of a contract in Rand, calculated at the

time of bid invitation, and includes all applicable taxes;

3. POINTS AWARDED FOR PRICE

3.1 THE 80/20 OR 90/10 PREFERENCE POINT SYSTEMS

A maximum of 80 or 90 points is allocated for price on the following basis:

80/20 or 90/10

















min

180

P

PPt

Ps

or

















min

190

P

PPt

Ps

Where

Ps = Points scored for price of bid under consideration

Pt = Price of bid under consideration

Pmin = Price of lowest acceptable bid

4. POINTS AWARDED FOR B-BBEE STATUS LEVEL OF CONTRIBUTOR

4.1 In terms of Regulation 6 (2) and 7 (2) of the Preferential Procurement Regulations,

preference points must be awarded to a bidder for attaining the B-BBEE status level of

contribution in accordance with the table below:

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 12

Page 3 of 5

3

B-BBEE Status Level of

Contributor

Number of points

(90/10 system)

Number of points

(80/20 system)

1 10 20

2 9 18

3 6 14

4 5 12

5 4 8

6 3 6

7 2 4

8 1 2

Non-compliant

contributor

0 0

5. BID DECLARATION

5.1 Bidders who claim points in respect of B-BBEE Status Level of Contribution must

complete the following:

6. B-BBEE STATUS LEVEL OF CONTRIBUTOR CLAIMED IN TERMS OF

PARAGRAPHS 1.4 AND 4.1

6.1 B-BBEE Status Level of Contributor: . = ………(maximum of 10 or 20 points)

(Points claimed in respect of paragraph 7.1 must be in accordance with the table

reflected in paragraph 4.1 and must be substantiated by relevant proof of B-BBEE

status level of contributor.

7. SUB-CONTRACTING

7.1 Will any portion of the contract be sub-contracted?

(Tick applicable box)

YES

NO

7.1.1 If yes, indicate:

i) What percentage of the contract will be

subcontracted............…………….…………%

ii) The name of the sub-contractor…………………………………………………………..

iii) The B-BBEE status level of the sub-contractor......................................……………..

iv) Whether the sub-contractor is an EME or QSE

(Tick applicable box)

YES

NO

v) Specify, by ticking the appropriate box, if subcontracting with an enterprise in terms

of Preferential Procurement Regulations,2017:

Designated Group: An EME or QSE which is at last 51% owned

by:

EME

√

QSE

√

Black people

Black people who are youth

Black people who are women

Black people with disabilities

Black people living in rural or underdeveloped areas or townships

Cooperative owned by black people

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 13

Page 4 of 5

4

Black people who are military veterans

OR

Any EME

Any QSE

8. DECLARATION WITH REGARD TO COMPANY/FIRM

8.1 Name of

company/firm:…………………………………………………………………………….

8.2 VAT registration

number:……………………………………….…………………………………

8.3 Company registration

number:…………….……………………….…………………………….

8.4 TYPE OF COMPANY/ FIRM

 Partnership/Joint Venture / Consortium

 One person business/sole propriety

 Close corporation

 Company

 (Pty) Limited

[T

ICK APPLICABLE BOX]

8.5 DESCRIBE PRINCIPAL BUSINESS ACTIVITIES

……………………………………………………………………………………………………

……..

8.6 COMPANY CLASSIFICATION

 Manufacturer

 Supplier

 Professional service provider

 Other service providers, e.g. transporter, etc.

[T

ICK APPLICABLE BOX]

8.7 Total number of years the company/firm has been in business:……………………………

8.8 I/we, the undersigned, who is / are duly authorised to do so on behalf of the

company/firm, certify that the points claimed, based on the B-BBE status level of

contributor indicated in paragraphs 1.4 and 6.1 of the foregoing certificate, qualifies the

company/ firm for the preference(s) shown and I / we acknowledge that:

i) The information furnished is true and correct;

ii) The preference points claimed are in accordance with the General Conditions as

indicated in paragraph 1 of this form;

iii) In the event of a contract being awarded as a result of points claimed as shown in

paragraphs 1.4 and 6.1, the contractor may be required to furnish documentary

proof to the satisfaction of the purchaser that the claims are correct;

iv) If the B-BBEE status level of contributor has been claimed or obtained on a

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 14

Page 5 of 5

5

fraudulent basis or any of the conditions of contract have not been fulfilled, the

purchaser may, in addition to any other remedy it may have –

(a) disqualify the person from the bidding process;

(b) recover costs, losses or damages it has incurred or suffered as a

result of that person’s conduct;

(c) cancel the contract and claim any damages which it has suffered as

a result of having to make less favourable arrangements due to such

cancellation;

(d) recommend that the bidder or contractor, its shareholders and

directors, or only the shareholders and directors who acted on a

fraudulent basis, be restricted by the National Treasury from

obtaining business from any organ of state for a period not

exceeding 10 years, after the audi alteram partem (hear the other

side) rule has been applied; and

(e) forward the matter for criminal prosecution.

……………………………………….

SIGNATURE(S) OF BIDDERS(S)

DATE: …………………………………..

ADDRESS …………………………………..

…………………………………..

WITNESSES

1. ……………………………………..

2. …………………………………….

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 15

HP06-2021SVP

DIRECTORS: CATEGORISATION OF RACE, GENDER AND DISABILITY

COMPLETE ALL FIELDS ELECTRONICALLY AND SIGN

PBD9

Full Names Surname

Identity Number or

foreigner Passport

Number

Age

(Number)

Race

Gender

(Male/Female)

Disability

(Yes/No)

24 JULY 2020 Page 1 of 3 SIGNED: ____________________________

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 16





DECLARATION OF

INTEREST

1. Any legal person, including persons employed by the state¹, or persons having a

kinship

with

persons employed by the state, including a blood relationship, may make an offer

or

offers in

terms of this invitation to bid (includes an advertised competitive bid, a limited bid,

a

proposal or

written price quotation). In view of possible allegations of favouritism, should

the

resulting bid, or

part thereof, be awarded to persons employed by the state, or

to

persons connected

with or related to them, it is required that the bidder or

his/her

authorized representative

declare his/her position in relation to the

evaluating/adjudicating

authority

where-

- the bidder is employed by the state;

and/or

- the legal person on whose behalf the bidding document is signed, has

a

relationship with persons/a person who are/is involved in the evaluation and

or

adjudication of

the bid(s), or where it is known that such a relationship

exists

between the person or

persons for or on whose behalf the declarant acts

and

persons who are involved with the

evaluation and or adjudication of the

bid.

2. In order to give effect to the above, the following questionnaire must be completed

and

submitted with the

bid.

2.1 Full name of bidder :

2.1.1 Represented by (Full Name):

2.2 Identity Number:

2.3 Position occupied in the company (director,

trustee, shareholder, member)

2.4 Registration number of company, enterprise,

close corporation, partnership agreement or trust

2.5 Tax Reference Number:

2.6 VAT Registration Number:

The names of all directors / trustees / shareholders / members, their individual identity

numbers,

tax reference

numbers and, if applicable, employee/PERSAL numbers must be indicated

in

paragraph 3

below

2.7 Are you or any person connected with the bidder

presently employed by the state?

If so, furnish the following particulars

Yes

No

2.7.1 Name of person / director / trustee / shareholder /

member:

Name of state institution at which you or the person

connected to the bidder is employed:

Position occupied in the state institution:

Any other particulars

2.7.2 If you are presently employed by the state, did you

obtain the appropriate authority to undertake

remunerative work outside employment in the public

sector?

Yes

No

If yes, did you attach pr oof of such aut hority to the

bid document?

Yes

No

2.7.3 If no, furnish reasons for non-submission of such

proof:

Note: Failure to submit proof of such authority, where

applicable, may result in

disqualification of the

bid.)

SBD

4

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 17

2.8 Did you or your spouse, or any of the

company’s directors /trustees / shareholders

/members or their spouses conduct

business with the state in the previous

twelve months?

Yes

No

2.8.1 If so, furnish particulars:

2.9 Do you, or any person with the bidder, have

any relationship (family, friend, other) with a

person employed by the state and who may

be involved with the evaluation and or

adjudication of this bid?

Yes

No

2.9.1 If so, furnish particulars:

2.10 Are you, or any person connected with the

bidder, aware of any relationship (family,

friend, other) between any other bidder

and any person employed by the state

who may be involved with the evaluation

and or adjudication of this bid?

Yes

No

2.10.1 If so, furnish particulars:

2.11 Do you or any of the directors / trustees /

shareholders / members of the company

have any interest in any other related

companies whether or not they are bidding

for this contract?

Yes

No

2.11.1 If so, furnish particulars:

¹“State” means

–

(a)

any national or provincial department, national or provincial public entity or constitutional institution within the meaning of

the

Public Finance Management Act, 1999 (Act No.

1

of 1999);

(b)

any municipality or municipal

entity;

(c)

provincial

legislature;

(d)

national Assembly or the national Council

of

provinces;

or

(e) Parliament.

²”Shareholder” means

a

person who owns shares in the company and

is

actively involved in the management of the enterprise

or

business and exercises control over the

enterprise

3 Full details of directors/trustees/members/shareholders. (Attach schedule if space insufficient)

Full Name

Identity Number

Personal Income Tax

Reference Number

State Employee Number

/ Persal Number

SBD 4

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 18



4. DECLARATION

I, the undersigned (full name)

Certify that the information furnished in paragraphs 2 and 3 above is correct.

I accept that the state may reject the bid or act against me should this declaration prove to

be false

Name of bidder

Position

Signature

Date

SBD

4

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 19



This document must be signed and submitted together with your bid

THE NATIONAL INDUSTRIAL PARTICIPATION P

ROGRAMME

INTRODUCTION

The National Industrial Participation (NIP) Programme, which is applicable to all government

procurement contracts that have an imported content, became effective on the 1 September 1996.

The NIP policy and guidelines were fully endorsed by Cabinet on 30 April 1997. In terms of the

Cabinet decision, all state and parastatal purchases / lease contracts (for goods, works and

services) entered into after this date, are subject to the NIP requirements. NIP is obligatory and

therefore must be complied with. The Industrial Participation Secretariat (IPS) of the Department of

Trade and Industry (DTI) is charged with the responsibility of administering the programme.

1. PILLARS OF THE PROGRAMME

1.1 The NIP obligation is benchmarked on the i m p o r t e d content of the c o n t r a c t . Any

contract having an imported content equal to or exceeding US$ 10 million or other

currency equivalent to US$ 10 million will have a NIP obligation. This threshold of US$ 10

million can be reached as follows:

a) Any single contract with imported content exceeding US$10 million.

b) Multiple contracts for the same goods, works or services each with imported content

exceeding US$3 million awarded to one seller over a 2 year period which in total exceeds

US$10 million.

c) A contract with a renewable option clause, where should the option be exercised the total

value of the imported content will exceed US$10 million.

d) Multiple suppliers of the same goods, works or services under the same contract, where the

value of the imported content of each allocation is equal to or exceeds US$ 3 million worth

of goods, works or services to the same government institution, which in total over a two (2)

year period exceeds US$10 million.

1.2 The NIP obligation applicable to suppliers in respect of sub-paragraphs 1.1 (a) to 1.1 (c)

above will amount to 30% of the imported content whilst suppliers in respect of paragraph 1.1

(d) shall incur 30% of the total NIP obligation on a pro-rata basis.

1.3 To satisfy the NIP obligation, the DTI would negotiate and conclude agreements such as

investments, joint ventures, sub-contracting, licensee production, export promotion, sourcing

arrangements and

research

and development (R&D)

with

partners

or suppliers.

1.4 A period of seven years has been identified as the time frame within which to

discharge

the

obligation.

2 REQUIREMENTS OF THE DEPARTMENT OF TRADE AND

INDUSTRY

2.1 In order to ensure effective implementation of the programme, successful bidders

(contractors) are required to, immediately after the award of a contract that is in excess of

R10 million (ten million Rands), submit details of such a contract to the DTI for reporting

purposes.

2.2 The purpose for reporting details of contracts in excess of the amount of R10 million (ten

million Rands) is to cater for multiple contracts for the same goods, works or services;

renewable contracts and multiple suppliers for the same goods, works or services under the

same contract as provided for in paragraphs 1.1.(b) to 1.1. (d) above.

SBD5

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 20



3 BID SUBMISSION AND CONTRACT REPORTING

REQ

UIRE

ME

NT

S O F BIDDERS AND

SUCCESSFUL BIDDERS (CONTRACTORS)

3.1 Bidders are required to

sign

and submit this

Standard

Bidding

Document (SBD

5) together with the

bid on the closing date and time.

3.2 In order to accommodate multiple contracts for the same goods, works or services;

renewable contracts and multiple suppliers for the same goods, works or services under the

same contract as indicated in sub-paragraphs 1.1 (b) to 1.1 (d) above and to enable the DTI

in determining the NIP obligation, successful bidders (contractors) are required, immediately

after being officially notified about any successful bid with a value in excess of R10 million (ten

million Rands), to contact and furnish the DTI with the following information:

• Bid/contract number.

• Description of the goods works or services.

• Date on which the contract was accepted.

• Name, address and contact details of the government institution.

• Value of the contract.

• Imported content of the contract, if possible.

3.3 The information required in paragraph 3.2 above must be sent to the Department of Trade and

Industry, Private Bag X84, Pretoria, 0001 for the attention of Mr Elias Malapane within

five (5) working days after award of the contract. for further details about the programme,

contact Mr Malapane on telephone (012) 394 1401, facsimile (012) 394 2401 or e-mail at

Elias@thedti.gov.za .

4 PROCESS TO SATISFY THE NIP OBLIGATION

4.1 Once the successful bidder (contractor) has made contact with and furnished the DTI with the

information required, the following steps will be followed:

a) the contractor and the DTI will determine the NIP obligation;

b) the contractor and the DTI will sign the NIP obligation agreement;

c) the contractor will submit a performance guarantee to the DTI;

d) the contractor will submit a business concept for consideration and approval by the DTI;

e) upon approval of the business concept by the DTI, the contractor will submit detailed

business plans outlining the business concepts;

f) the contractor will implement the business plans; and

g) the contractor will submit bi-annual progress reports on approved plans to the DTI.

4.2 The NIP obligation agreement is between the DTI and the successful bidder (contractor) and,

therefore, does not involve the purchasing institution.

Bid number

Closing

date:

Name of bidder

Postal Address

Postal Code

Name in print

Position

Signature:

Date:

SBD5

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 21

HP06-2021SVP

24/08/2020



DECLARATION OF BIDDER’S PAST SUPPLY CHAIN MANAGEMENT

PRACTICES

1 This Standard Bidding Document must form part of all bids invited.

2 It serves as a declaration to be used by institutions in ensuring that when goods and

services are being procured, all reasonable steps are taken to combat the abuse of

the supply chain management system.

3 The bid of any bidder may be disregarded if that bidder or any of its directors have- a)

abused the institution’s supply chain management system;

b) committed fraud or any other improper conduct in relation to such system; or

c) failed to perform on any previous contract.

4 In order to give effect to the above, the following questionnaire must be

completed and submitted with the bid.

Item Question Yes No

4.1 Is the

bidder

or any of its

directors listed

on the

National

Treasury’s

Database

of

Restricted

Suppliers as

companies

or persons

prohibited

from

doing

business

with the

public

sector?

(Companies or persons who are listed on this Database were informed in

writing of this restriction by the Accounting Officer/Authority of the institution that

imposed the restriction after the audi alteram partem rule was applied).

The Database of Restricted Suppliers now resides on the National

Treasury’s website (www.treasury.gov.za) and can be accessed by

clicking on its link at the bottom of the home page.

4.1.1 If so, furnish particulars:

4.2

Is the bidder or any of its directors listed on the Register for Tender

Defaulters

in terms of section 29 of the

Prevention

and

Combating

of

Corrupt Activities Act (No 12 of 2004)?

Register for Tender Defaulters can be accessed on the National

Treasury’s website

(www.treasury.gov.za)

by clicking on its link at the

bottom of the home page.

4.2.1 If so, furnish particulars:

SBD8

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 22



4.3

Was the bidder or any of its directors

convicted

by a court of law

(including

a court outside of the Republic of South Africa) for fraud or

corruption

during the past five years?

4.3.1 If so, furnish particulars:

4.4 Was any contract between the bidder and any organ of state terminated

during the past five years on account of failure to perform on or comply with

the contract?

4.4.1 If so, furnish particulars:

Certification

I, the undersigned

certify that the information furnished on this declaration form is true and correct. I accept that, in

addition to cancellation of a contract, action may be taken against me should this declaration prove

to be false.

I accept that the state may reject the bid or act against me should t h i s declaration prove to be

false.

Name of bidder:

Position:

Signature:

Date

SBD8

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 23



CERTIFICATE OF INDEPENDENT BID

DETERMINATION

1. This Standard Bidding Document (SBD) must form part of all bids¹

invited.

2.

Section 4 (1) (b) (iii) of the Competition Act No. 89 of 1998, as amended, prohibits

an

agreement between, or concerted practice by, firms, or a decision by an association

of

firms, if

it is between parties in a horizontal relationship and if it involves

collusive

bidding (or bid

rigging).² Collusive bidding is a pe se prohibition meaning that it

cannot

be justified under any

grounds.

¹ Includes price quotations, advertised competitive bids, limited bids and

proposals.

² Bid rigging (or collusive bidding) occurs when businesses, that would otherwise be expected to

compete, secretly conspire to

raise

prices or lower the quality of goods and / or services for

purchasers who wish to acquire goods and / or services through

a

bidding process. Bid rigging is,

therefore, an agreement between competitors not to

compete

3.

Treasury Regulation 16A9 prescribes that accounting officers and accounting

authorities

must

take all reasonable steps to prevent abuse of the supply chain management

system

and authorizes

accounting officers and accounting authorities

to:

a. disregard the bid of any bidder if that bidder, or any of its directors

have

abused the institution’s supply chain management system and or committed

fraud

or any

other improper conduct in relation to such

system.

b. cancel a contract awarded to a supplier of goods and services if the

supplier

committed any corrupt or fraudulent act during the bidding process or the

execution

of that

contract.

4. This SBD serves as a certificate of declaration th at would be used by institutions to en sure

that, when bids are considered, reasonable steps are taken to prevent any form of bid rigging.

5. In order to give effect to the above, the attached Certificate of Bid Determination (SBD9) must be

completed and submitted with the bid:

CERTIFICATE OF INDEPENDENT BID

DETERMINATION

I, the undersigned, in submitting the accompanying

bid…………………………………………………………,

in response to the invitation for the bid made by the Department Of Health, do hereby make the following

statements that I certify to be true and complete in every respect:

I

certify, on behalf

of

that

1. I have read and I understand the contents of this

Certificate;

2. I understand that the accompanying bid will be disqualified if this Certificate is found not

to

be

true and complete in every

respect;

3. I am authorised by the bidder to sign this Certificate, and to submit the accompanying bid,

on

behalf of the

bidder;

4. Each person whose signature appears on the accompanying bid has been authorised

by

the

bidder to determine the terms of, and to sign the bid, on behalf of the

bidder;

SBD9

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 24

SUPPLY AND DELIVERY

OF SMALL VOLUME

PARENTERALS AND

INSULIN DEVICES

HP06-2021SVP



5. For the purposes of this Certificate and the accompanying bid, I understand that the

word

“competitor” shall include any individual or organization, other than the bidder, whether or

not

affiliated with the bidder,

who:

a. has been requested to submit a bid in response to this bid

invitation;

b. could potentially submit a bid in response to this bid invitation, based on

their

qualifications, abilities or experience;

and

c. provides the same goods and services as the bidder and/or is in the same line of

business

as the

bidder.

6.

The bidder has arrived at the accompanying bid independently from, and without

consultation,

communication, agreement or arrangement with any competitor. However

communication

between partners in a joint venture or consortium³ will not be construed as collusive

bidding.

7. In particular, without limiting the generality of paragraphs 6 above, there has been no consultation,

communication, agreement or arrangement with any competitor regarding:

a. prices;

b. geographical area where product or service will be rendered (market allocation)

c. methods, factors or formulas used to calculate prices;

d. the intention or decision to submit or not to submit, a bid;

e. the submission of a bid which does not meet the specifications and conditions of the bid; or

f. bidding with the intention not to win the bid.

8. In addition, there have been no consultations, communications, agreements or arrangements with

any competitor regarding the quality, quantity, specifications and conditions or delivery particulars

of the products or services to which this bid invitation relates.

9. The terms of the accom panying bid have not been, and will n ot be, disclo sed by the bidder,

directly or indirectly, to any competito r, prior to the date and time of the official bid openi ng or of

the awarding of the contract.

10. I am aware that, in addition and without prejudice to any other remedy provided to combat any

restrictive practices related to bids and contracts, bids that are suspicious will be reported to the

Competition Commission for investigation and po ssible imposition of administ rative penalties in

terms of section 59 of the Competition Act No 89 of 1998 and or may be reported to the National

Prosecuting Authority (NPA) for criminal investigation and or may be restri cted from conducting

business with the public sector for a period not exceeding ten (10) years in terms of the Prevention

and Combating of Corrupt Activities Act No 12 of 2004 or any other applicable legislation.

Name of Bidder

Full Name

Postion

Signature

Date

³ Joint venture or Consortium means an association of persons for the purpose of

combining their expertise, property, capital, efforts, skill and knowledge in an activity

for the execution of a contract.

SBD9

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 25



AUTHORISATION DECLARATION (PBD1)

NAME OF THE BIDDER

Are you sourcing the products from a third party? Yes No

* If you have answered YES to the above question, please provide full details in the table below of

the third party (ies) from whom you are sourcing the products.

1. Declaration by the bidder where the bidder is sourcing the products from a third party.

The bidder hereby declares the following:-

1.1 The bidder is sourcing the products listed in the PBD1.1 attached, from a third party in

order to comply with the terms and conditions of the bid.

1.2 The bidder has informed the third party of the terms and conditions of the bid and the third party

is acquainted with the said terms and the description of the products listed in the PBD1.1.

1.3 The bidder has received the attached, unconditional written undertaking from the third party

to supply the products listed in the PBD1.1 in accordance with the terms and conditions of the

bid document for the duration of the contract. A template has been attached (PBD1.2) that is to

be used for

th

e purpose of the third party undertaking.

1.4 The bidder confirms that all f inancial and supply arrangements for the products have been

mutually agreed upon between the bidder and the third party.

2. The bidder declares that the information contained herein is true and correct.

3. The bidder acknowledges that the Department of Health reserves the right to verify the

information contained therein and if found to be false or incorrect may invoke any remedies available

to it in the bid documents.

Signed at

on the

day of

Full Names

Designation

Signature

PBD1

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 26



List of the products offered sourced from third party

Bid Item

No

Brand

Name

Name of the company

from

where the

products will

be sourced

Address and contact details of the

company

from

where the products will be

sourced

PBD1.1

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 27



List of the products offered sourced from third

party -

continued

Bid Item

No

Brand

Name

Name of the company

from

where the

products will

be sourced

Address and contact details of the

company

from

where the products will be

sourced

(Should the table provided not be sufficient for all the items offered, please provide additional information as an attachment and it must be properly

referenced to

this document)

PBD1.1

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 28



Template for unconditional written undertaking from the third party

Note:

The authorisation letter must be on the official letterhead of the third party

A separate letter must be included for each third party

The authorisation letter must be addressed to the Bidding Company

Name of Bidding Company: ________________________________________

Address of Bidding Company: ______________________________________

_______________________________________________________________

Attention: _______________________________________________________

Dear Sir/Madam

AUTHORISATION

LETTER:

CONTRACT

NO _______________

We, (Name of Third Party)

hereby authorise you, (Name of Company) to include the

products listed below in your bid submission for the abovementioned contract.

We confirm that we have firm supply arrangements in place, and have familiarised

ourselves with the

item

descriptions, specifications and bid conditions relating to item/s listed below.

Item no. Description of product Brand name

(Should the table provided not be sufficient for all the items offered, please provide additional

information as an attachment and it must be properly referenced to this document)

Yours faithfully,

Signature of the Third Party: Date:

PBD1.2

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 29

PBD5 DECLARATION OF COMPLIANCE WITH GOOD MANUFACTURING

PRACTICE (GMP)

To be signed by the Chief Executive Officer of the Company in terms of this bid.

I,………………………………………………………………………………………………………

(Full name) being the Chief Executive Officer

Of……………………………………………………………………………………………………

(Organisation name) hereby certify that to the best of my knowledge all reasonable steps have

been taken to ensure that:

a) There are no outstanding or impending GMP or legal matters that may have a material

impact on the Company’s ability to perform in terms of this contract.

b) In terms of this declaration, I undertake to inform the Department of Health at first knowledge

of any circumstances that may result in interrupted supply.

c) (Organisation name).................................................................. has complied with all the

legal requirements as stipulated in terms of Medicines and Related Substances Act 101 of

1965, as amended,: for such products offered.

…………………………………………………………………………………………

Full Name of Chief Executive Officer

…………………………………………………………………………………………

Full Identity Number/or equivalent of the Chief Executive Officer

…………………………………………………………………………………………

Signature of Chief Executive Officer

…………………………………………………………………………………………

Signature of Witness

…………………………………………………………………………………………………….

Signed at Date

PBD5

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 30

 PBD 8

PBD 8: DECLARATION OF COMPLIANCE WITH THE SPECIAL REQUIREMENTS

AND CONDITIONS OF CONTRACT

To be signed by the Chief Executive Officer of the Company in terms of this bid.

I,…………………………………………………………………………………………… (Full name)

being the Chief Executive Officer

of…………………………………………………………………………………………(Organisation name)

hereby declare that to the best of my knowledge all reasonable steps have been taken to ensure

that:

a) (Organisation name)............................................................................................. has complied

with all the legal requirements as provided in the Medicines and Related Substances Act

101 of 1965, as amended, for such products offered;

b) There are no outstanding or impending matters (including GMP or legal) that may have a

material impact on the Company’s ability to perform in terms of this contract

In terms of this declaration, I undertake to inform the Department of Health at first knowledge of any

circumstances that may result in interrupted supply of product if the contract is awarded.

I further declare that

……………………………………………………………………………………(Organisation name)

will comply with the requirements and conditions as stipulated in the Special Requirements and

Conditions of Contract

…………………………………………………………………………………………

Full Name of Chief Executive Officer

…………………………………………………………………………………………

Full Identity Number/or equivalent of the Chief Executive Officer

…………………………………………………………………………………………

Signature of Chief Executive Officer

…………………………………………………………………………………………

Signature of Witness

Date Signed ....................................................... at ...........................................



2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 31



Definition of fields in Bid Response Document, to be read in conjunction with the Special

Requirements and

Conditions of Contract

Field Name Field Definition

FIELDS WHICH ARE PRE-FILLED AND MAY NOT BE ALTERED

Item Number The relevant item number which will be used throughout the contract period.

Each item number is linked to a specification

Item Specification The specification of the item for which a call for bids has been issued, as linked to

the item number.

Unit The unit of measure for the specification. This determines how the estimates are

expressed and how the price should be quoted. This may be one injection or one

pack of 100 tablets, etc.

Estimate The estimated quantities associated with the item number and specification,

for the full contract period. Estimates are expressed in unit packs.

FIELDS WHICH ARE TO BE COMPLETED BY THE BIDDER FOR ALL ITEMS ON WHICH BIDS ARE

OFFERED

Regis

t

ered legal

name of bidder

The full, regis

t

ered, legal name of

t

he bidder, as on VAT regis

t

ration certifica

t

eand

Medicine Re

g

is

t

ration Certifica

t

ea

p

lican

t

.

Quantity for full period

The volume of the item (expressed in units) which the bidder can provide

durin

g

the com

p

lete

p

eriod of the tender

Delivered price in ZAR

Final price offered by a bidder for an item number as per specification, which

includes VAT and deliver

y

. Must be the

p

rice fo

r

a unit as advertised.

Registered Product Name Brand name. Must correspond with Medicine Registration Certificate (1) GW12/7

Conforms to specification? Confirm whether or not the product on offer conforms exactly to the Item

Specification.

If NO: De

t

ail devia

t

ion

from specification.

Detail exact deviation from Item Specification, as per registration of product on

offer.

Product Registration

Number

As per Medicine Registration Certificate Certificate(2) GW12/7

License to Manufac

t

ure

Medicines:

License Number , Expiry

date

As per License to Manufacture Medicines – this must correspond with the

document submitted

Pack Size Offered: Unit

pack

Single unit offered according to specification in numbers e.g. each (1) This must

correspond with the delivered price.

Pack Size Offered: Shelf

Pack

Number of Unit Packs within the smallest wrap (e.g. 10 ampoules)

Standard units in: Shipper

Pack

Number of unit packs in a shipper / bulk box

Lead-Time Interval between receipt of an order until delivery at facility which placed the order.

Must not exceed 14 calendar days.

Initial lead time Interval between award of the tender and ability to fill an order. This must not

exceed 75 calendar days.

Minimum Order Quantity The lowest acceptable quantity for a given purchase order.

Batch size for

t

he bid

item, in number of

p

acks

Batch size, expressed in number of units

Monthly batch capacity

Monthly batch capacity that will be assigned for the bid item for the duration of the

contract expressed in number of batches.

Technical amendment

required?

Do you require a technical amendment to perform according to the conditions of

your bid Y/N

If YES: Provide details Provide all relevant details (can be provided in a covering letter)

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 32



Definition of fields in Bid Response Document, to be read in conjunction with the Special

Requirements and

Conditions of Contract

Field Name Field Definition

EAN 13 Barcode for Unit

Pack

Provide Number

EAN 13 Barcode for Shelf

Pack

Provide Number

ITF14 Barcode for Shipper

Pack

Provide Number

2D Barcode or Similar Provide Number

NAPPI Code Provide Code

Manufacturer As per MCC Certificate (8) GW12/7 – List all sources

SEP Price

The most recently approved Single Exit Price expressed in corresponding unit to

bid

Are any of the listed

manufacturers

etc. 3rd parties to the

bidder?

Y/N

If YES - complete PBD1 and include letter(s) of authorisation as applicable

API Source Full Site Name

(x3)

Full name of API source, including company name and site – List all sources

API Source Full Address Full physical address of API source – List all sources

API Source Country Country of API source – List all sources

API Source Contact Listed contact information

PRICING COMPONENT BREAKDOWN

Note: VAT must be apportioned equally across all components. Please see pricing section in Special Conditions

Percentage of Delivered

Price attributable to API

The percentage of the Delivered Price associated with API, (the therapeutically

active component of the medicine). Should an item be imported as finished

product, the component may be reflected as part of formulation cost.

Imported (API) Portion of API component attributable to imported expenditure

Percentage of Delivered

Price attributable to

Formulation

The percentage of the delivered price associated with Formulation, (includes all

operations in the process of which different chemical substances, including the

API, are combined to produce a final medicinal product), includes material,

processing, production, quality assurance and related controls.

Local (Formulation) Portion of Formulation component attributable to local expenditure

Imported (Formulation) Portion of Formulation component attributable to imported expenditure

Packaging The percentage of the Delivered Price associated with Packaging, where

packaging includes all operations in the process of packaging medicine into

primary and/or secondary packaging, packaging material and labels.

Local (Packaging) Portion of Packaging component attributable to local expenditure

Imported (Packaging) Portion of Packaging component attributable to imported expenditure

Logistics Percentage of delivered price associated with logistics, where logistics includes

all operations, taking place within the Republic of South Africa, relating to the

storage, distribution and transportation of medicine to the healthcare facility or

pharmaceutical depot.

Gross Margin Percentage of delivered price not associated with API, Formulation, Packaging,

or Logistics.

Currency Primary currency in which manufacturer trades for imported components



2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 33

1

THE NATIONAL TREASURY

Republic of South Africa

_____________________________________________________________________

GOVERNMENT PROCUREMENT:

GENERAL CONDITIONS OF CONTRACT

July 2010

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 34

2

GOVERNMENT PROCUREMENT

GENERAL CONDITIONS OF CONTRACT

July 2010

NOTES

The purpose of this document is to:

(i) Draw special attention to certain general conditions

applicable to government bids, contracts and orders; and

(ii) To ensure that clients be familiar with regard to the rights

and obligations of all parties involved in doing business

with government.

In this document words in the singular also mean in the plural

and vice versa and words in the masculine also mean in the

feminine and neuter.

• The General Conditions of Contract will form part of

all bid documents and may not be amended.

• Special Conditions of Contract (SCC) relevant to a specific

bid, should be compiled separately for every bid (if

(applicable) and will supplement the General Conditions

of Contract. Whenever there is a conflict, the provisions

in the SCC shall prevail.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 35

3

TABLE OF CLAUSES

1. Definitions

2. Application

3. General

4. Standards

5. Use of contract documents and information; inspection

6. Patent rights

7. Performance security

8. Inspections, tests and analysis

9. Packing

10. Delivery and documents

11. Insurance

12. Transportation

13. Incidental services

14. Spare parts

15. Warranty

16. Payment

17. Prices

18. Contract amendments

19. Assignment

20. Subcontracts

21. Delays in the supplier’s performance

22. Penalties

23. Termination for default

24. Dumping and countervailing duties

25. Force Majeure

26. Termination for insolvency

27. Settlement of disputes

28. Limitation of liability

29. Governing language

30. Applicable law

31. Notices

32. Taxes and duties

33. National Industrial Participation Programme (NIPP)

34. Prohibition of restrictive practices

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 36

4

General Conditions of Contract

1. Definitions

1. The following terms shall be interpreted as indicated:

1.1 “Closing time” means the date and hour specified in the bidding

documents for the receipt of bids.

1.2 “Contract” means the written agreement entered into between the

purchaser and the supplier, as recorded in the contract form signed by

the parties, including all attachments and appendices thereto and all

documents incorporated by reference therein.

1.3 “Contract price” means the price payable to the supplier under the

contract for the full and proper performance of his contractual

obligations.

1.4 “Corrupt practice” means the offering, giving, receiving, or soliciting

of any thing of value to influence the action of a public official in the

procurement process or in contract execution.

1.5 "Countervailing duties" are imposed in cases where an enterprise

abroad is subsidized by its government and encouraged to market its

products internationally.

1.6 “Country of origin” means the place where the goods were mined,

grown or produced or from which the services are supplied. Goods are

produced when, through manufacturing, processing or substantial and

major assembly of components, a commercially recognized new

product results that is substantially different in basic characteristics or

in purpose or utility from its components.

1.7 “Day” means calendar day.

1.8 “Delivery” means delivery in compliance of the conditions of the

contract or order.

1.9 “Delivery ex stock” means immediate delivery directly from stock

actually on hand.

1.10 “Delivery into consignees store or to his site” means delivered and

unloaded in the specified store or depot or on the specified site in

compliance with the conditions of the contract or order, the supplier

bearing all risks and charges involved until the supplies are so

delivered and a valid receipt is obtained.

1.11 "Dumping" occurs when a private enterprise abroad market its goods

on own initiative in the RSA at lower prices than that of the country of

origin and which have the potential to harm the local industries in the

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 37

5

RSA.

1.12 ”Force majeure” means an event beyond the control of the supplier and

not involving the supplier’s fault or negligence and not foreseeable.

Such events may include, but is not restricted to, acts of the purchaser

in its sovereign capacity, wars or revolutions, fires, floods, epidemics,

quarantine restrictions and freight embargoes.

1.13 “Fraudulent practice” means a misrepresentation of facts in order to

influence a procurement process or the execution of a contract to the

detriment of any bidder, and includes collusive practice among bidders

(prior to or after bid submission) designed to establish bid prices at

artificial non-competitive levels and to deprive the bidder of the

benefits of free and open competition.

1.14 “GCC” means the General Conditions of Contract.

1.15 “Goods” means all of the equipment, machinery, and/or other materials

that the supplier is required to supply to the purchaser under the

contract.

1.16 “Imported content” means that portion of the bidding price represented

by the cost of components, parts or materials which have been or are

still to be imported (whether by the supplier or his subcontractors) and

which costs are inclusive of the costs abroad, plus freight and other

direct importation costs such as landing costs, dock dues, import duty,

sales duty or other similar tax or duty at the South African place of

entry as well as transportation and handling charges to the factory in

the Republic where the supplies covered by the bid will be

manufactured.

1.17 “Local content” means that portion of the bidding price which is not

included in the imported content provided that local manufacture does

take place.

1.18 “Manufacture” means the production of products in a factory using

labour, materials, components and machinery and includes other

related value-adding activities.

1.19 “Order” means an official written order issued for the supply of goods

or works or the rendering of a service.

1.20 “Project site,” where applicable, means the place indicated in bidding

documents.

1.21 “Purchaser” means the organization purchasing the goods.

1.22 “Republic” means the Republic of South Africa.

1.23 “SCC” means the Special Conditions of Contract.

1.24 “Services” means those functional services ancillary to the supply of

the goods, such as transportation and any other incidental services,

such as installation, commissioning, provision of technical assistance,

training, cat

ering, gardening, security, maintenance and other such

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 38

6

obligations of the supplier covered under the contract.

1.25 “Written” or “in writing” means handwritten in ink or any form of

electronic or mechanical writing.

2. Application

2.1 These general conditions are applicable to all bids, contracts and orders

including bids for functional and professional services, sales, hiring,

letting and the granting or acquiring of rights, but excluding

immovable property, unless otherwise indicated in the bidding

documents.

2.2 Where applicable, special conditions of contract are also laid down to

cover specific supplies, services or works.

2.3 Where such special conditions of contract are in conflict with these

general conditions, the special conditions shall apply.

3. General

3.1 Unless otherwise indicated in the bidding documents, the purchaser

shall not be liable for any expense incurred in the preparation and

submission of a bid. Where applicable a non-refundable fee for

documents may be charged.

3.2 With certain exceptions, invitations to bid are only published in the

Government Tender Bulletin. The Government Tender Bulletin may be

obtained directly from the Government Printer, Private Bag X85,

Pretoria 0001, or accessed electronically from www.treasury.gov.za

4. Standards

4.1 The goods supplied shall conform to the standards mentioned in the

bidding documents and specifications.

5. Use of

contract

documents

and

information;

inspection.

5.1 The supplier shall not, without the purchaser’s prior written consent,

disclose the contract, or any provision thereof, or any specification,

plan, drawing, pattern, sample, or information furnished by or on

behalf of the purchaser in connection therewith, to any person other

than a person employed by the supplier in the performance of the

contract. Disclosure to any such employed person shall be made in

confidence and shall extend only so far as may be necessary for

purposes of such performance.

5.2 The supplier shall not, without the purchaser’s prior written consent,

make use of any document or information mentioned in GCC clause

5.1 except for purposes of performing the contract.

5.3 Any document, other than the contract itself mentioned in GCC clause

5.1 shall remain the property of the purchaser and shall be returned (all

copies) to the purchaser on completion of the supplier’s performance

under the contract if so required by the purchaser.

5.4 The supplier shall permit the purchaser to inspect the supplier’s records

relating to the performance of the supplier and to have them audited by

auditors appointed by the purchaser, if so required by the purchaser.

6. Patent rights

6.1 The supplier shall indemnify the purchaser against all third-party

claims of infringement of patent, trademark, or industrial de

sign rights

arising from use of the goods or any part thereof by the purchaser.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 39

7

7. Performance

security

7.1 Within thirty (30) days of receipt of the notification of contract award,

the successful bidder shall furnish to the purchaser the performance

security of the amount specified in SCC.

7.2 The proceeds of the performance security shall be payable to the

purchaser as compensation for any loss resulting from the supplier’s

failure to complete his obligations under the contract.

7.3 The performance security shall be denominated in the currency of the

contract, or in a freely convertible currency acceptable to the purchaser

and shall be in one of the following forms:

(a) a bank guarantee or an irrevocable letter of credit issued by a

reputable bank located in the purchaser’s country or abroad,

acceptable to the purchaser, in the form provided in the

bidding documents or another form acceptable to the

purchaser; or

(b) a cashier’s or certified cheque

7.4 The performance security will be discharged by the purchaser and

returned to the supplier not later than thirty (30) days following the

date of completion of the supplier’s performance obligations under the

contract, including any warranty obligations, unless otherwise

specified in SCC.

8. Inspections,

tests and

analyses

8.1 All pre-bidding testing will be for th

e account of the bidder.

8.2 If it is a bid condition that supplies to be produced or services to be

rendered should at any stage during production or execution or on

completion be subject to inspection, the premises of the bidder or

contractor shall be open, at all reasonable hours, for inspection by a

representative of the Department or an organization acting on behalf of

the Department.

8.3 If there are no inspection requirements indicated in the bidding

documents and no mention is made in the contract, but during the

contract period it is decided that inspections shall be carried out, the

purchaser shall itself make the necessary arrangements, including

payment arrangements with the testing authority concerned.

8.4 If the inspections, tests and analyses referred to in clauses 8.2 and 8.3

show the supplies to be in accordance with the contract requirements,

the cost of the inspections, tests and analyses shall be defrayed by the

purchaser.

8.5 Where the supplies or services referred to in clauses 8.2 and 8.3 do not

comply with the contract requirements, irrespective of whether such

supplies or services are accepted or not, the cost in connection with

these inspections, tests or analyses shall be defrayed by the supplier.

8.6 Supplies and services which are referred to in clauses 8.2 and 8.3 and

which do not comply with the contract requirements may be rejected.

8.7

Any contract supplies may on or after

delivery be inspected, tested or

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 40

8

analyzed and may be rejected if found not to comply with the

requirements of the contract. Such rejected supplies shall be held at the

cost and risk of the supplier who shall, when called upon, remove them

immediately at his own cost and forthwith substitute them with

supplies which do comply with the requirements of the contract.

Failing such removal the rejected supplies shall be returned at the

suppliers cost and risk. Should the supplier fail to provide the

substitute supplies forthwith, the purchaser may, without giving the

supplier further opportunity to substitute the rejected supplies,

purchase such supplies as may be necessary at the expense of the

supplier.

8.8 The provisions of clauses 8.4 to 8.7 shall not prejudice the right of the

purchaser to cancel the contract on account of a breach of the

conditions thereof, or to act in terms of Clause 23 of GCC.

9. Packing

9.1 The supplier shall provide such packing of the goods as is required to

prevent their damage or deterioration during transit to their final

destination, as indicated in the contract. The packing shall be

sufficient to withstand, without limitation, rough handling during

transit and exposure to extreme temperatures, salt and precipitation

during transit, and open storage. Packing, case size and weights shall

take into consideration, where appropriate, the remoteness of the

goods’ final destination and the absence of heavy handling facilities at

all points in transit.

9.2 The packing, marking, and documentation within and outside the

packages shall comply strictly with such special requirements as shall

be expressly provided for in the contract, including additional

requirements, if any, specified in SCC, and in any subsequent

instructions ordered by the purchaser.

10. Delivery

and documents

10.1 Delivery of the goods shall be made by th

e supplier in accordance with

the terms specified in the contract. The details of shipping and/or other

documents to be furnished by the supplier are specified in SCC.

10.2 Documents to be submitted by the supplier are specified in SCC.

11. Insurance

11.1 The goods supplied under the contract shall be fully insured in a freely

convertible currency against loss or damage incidental to manufacture

or acquisition, transportation, storage and delivery in the manner

specified in the SCC.

12. Transportation

12.1 Should a price other than an all-inclusive delivered price be required,

this shall be specified in the SCC.

13. Incidental

services

13.1 The supplier may be required to provide any or all of the following

services, including additional services, if any, specified in SCC:

(a) performance or supervision of on-

site assembly and/or

commissioning of the supplied goods;

(b) furnishing of tools required for assembly and/or maintenance

of the supplied goods;

(c) furnishing of a detailed operations and maintenance manual

for each appropriate unit of the supplied goods;

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 41

9

(d) performance or supervision or maintenance and/or repair of

the supplied goods, for a period of time agreed by the parties,

provided that this service shall not relieve the supplier of any

warranty obligations under this contract; and

(e) training of the purchaser’s personnel, at the supplier’s plant

and/or on-site, in assembly, start-up, operation,

maintenance, and/or repair of the supplied goods.

13.2 Prices charged by the supplier for incidental services, if not included in

the contract price for the goods, shall be agreed upon in advance by the

parties and shall not exceed the prevailing rates charged to other

parties by the supplier for similar services.

14. Spare parts

14.1 As specified in SCC, the supplier may be required to provide any or all

of the following materials, notifications, and information pe

rtaining to

spare parts manufactured or distributed by the supplier:

(a) such spare parts as the purchaser may elect to purchase from the

supplier, provided that this election shall not relieve the supplier

of any warranty obligations under the contract; and

(b) in the event of termination of production of the spare parts:

(i) Advance notification to the purchaser of the pending

termination, in sufficient time to permit the purchaser to

procure needed requirements; and

(ii) following such termination, furnishing at no cost to the

purchaser, the blueprints, drawings, and specifications of the

spare parts, if requested.

15. Warranty

15.1 The supplier warrants that the goods supplied under the contract are

new, unused, of the most recent or current models, and that they

incorporate all recent improvements in design and materials unless

provided otherwise in the contract. The supplier further warrants that

all goods supplied under this contract shall have no defect, arising from

design, materials, or workmanship (except when the design and/or

material is required by the purchaser’s specifications) or from any act

or omission of the supplier, that may develop under normal use of the

supplied goods in the conditions prevailing in the country of final

destination.

15.2 This warranty shall remain valid for twelve (12) months after the

goods, or any portion thereof as the case may be, have been delivered

to and accepted at the final destination indicated in the contract, or for

eighteen (18) months after the date of shipment from the port or place

of loading in the source country, whichever period concludes earlier,

unless specified otherwise in SCC.

15.3 The purchaser shall promptly notify the supplier in writing of any

claims arising under this warranty.

15.4 Upon receipt of such notice, the supplier shall, within the period

specified in SCC and with all reasonable speed, repair or replace the

defective goods or parts thereof, without costs to the purchaser.

15.5 If the supplier, having been notified, fails to remedy the defect(s)

within the p

eriod specified in SCC, the purchaser may proceed to take

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 42

10

such remedial action as may be necessary, at the supplier’s risk and

expense and without prejudice to any other rights which the purchaser

may have against the supplier under the contract.

16. Payment

16.1 The method and conditions of payment to be made to the supplier

under this contract shall be specified in SCC.

16.2 The supplier shall furnish the purchaser with an invoice accompanied

by a copy of the delivery note and upon fulfillment of other obligations

stipulated in the contract.

16.3 Payments shall be made promptly by the purchaser, but in no case later

than thirty (30) days after submission of an invoice or claim by the

supplier.

16.4 Payment will be made in Rand unless otherwise stipulated in SCC.

17. Prices

17.1 Prices charged by the supplier for goods delivered and services

performed under the contract shall not vary from the prices quoted by

the supplier in his bid, with the exception of any price adjustments

authorized in SCC or in the purchaser’s request for bid validity

extension, as the case may be.

18. Contract

amendments

18.1 No variation in or modification of the terms of the contract shall be

made except by written amendment signed by the parties concerned.

19. Assignment

19.1 The supplier shall not assign, in whole or in part, its obligations to

perform under the contract, except with the purchaser’s prior written

consent.

20. Subcontracts

20.1 The supplier shall notify the purchaser in writing of all subcontracts

awarded under this contracts if not already specified in the bid. Such

notification, in the original bid or later, shall not relieve the supplier

from any liability or obligation under the contract.

21. Delays in the

supplier’s

performance

21.1 Delivery of the goods and performance of services shall be made by

the supplier in accordance with the time schedule prescribed by the

purchaser in the contract.

21.2 If at any time during performance of the contract, the supplier or its

subcontractor(s) should encounter conditions impeding timely delivery

of the goods and performance of services, the supplier shall promptly

notify the purchaser in writing of the fact of the delay, its likely

duration and its cause(s). As soon as practicable after receipt of the

supplier’s notice, the purchaser shall evaluate the situation and may at

his discretion extend the supplier’s time for performance, with or

without the imposition of penalties, in which case the extension shall

be ratified by the parties by amendment of contract.

21.3 No provision in a contract shall be deemed to prohibit the obtaining of

supplies or services from a national department, provincial department,

or a local authority.

21.4 The right is reserved to procure outside of the contract small quantities

or to have minor essential services executed if an emergency arises, the

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 43

11

supplier’s point of supply is not situated at or near the place where the

supplies are required, or the supplier’s services are not readily

available.

21.5 Except as provided under GCC Clause 25, a delay by the supplier in

the performance of its delivery obligations shall render the supplier

liable to the imposition of penalties, pursuant to GCC Clause 22,

unless an extension of time is agreed upon pursuant to GCC Clause

21.2 without the application of penalties.

21.6 Upon any delay beyond the delivery period in the case of a supplies

contract, the purchaser shall, without canceling the contract, be entitled

to purchase supplies of a similar quality and up to the same quantity in

substitution of the goods not supplied in conformity with the contract

and to return any goods delivered later at the supplier’s expense and

risk, or to cancel the contract and buy such goods as may be required

to complete the contract and without prejudice to his other rights, be

entitled to claim damages from the supplier.

22. Penalties

22.1 Subject to GCC Clause 25, if the supplier fails to deliver any or all of

the goods or to perform the services within the period(s) sp

ecified in

the contract, the purchaser shall, without prejudice to its other remedies

under the contract, deduct from the contract price, as a penalty, a sum

calculated on the delivered price of the delayed goods or unperformed

services using the current prime interest rate calculated for each day of

the delay until actual delivery or performance. The purchaser may also

consider termination of the contract pursuant to GCC Clause 23.

23. Termination

for default

23.1 The purchaser, without prejudice to any other remedy for breach of

contract, by written notice of default sent to the supplier, may

terminate this contract in whole or in part:

(a)

if the supplier fails to deliver any or all of the goods within

the period(s) specified in the contract, or within any

extension thereof granted by the purchaser pursuant to GCC

Clause 21.2;

(b) if the Supplier fails to perform any other obligation(s) under

the contract; or

(c) if the supplier, in the judgment of the purchaser, has

engaged in corrupt or fraudulent practices in competing for

or in executing the contract.

23.2 In the event the purchaser terminates the contract in whole or in part,

the purchaser may procure, upon such terms and in such manner as it

deems appropriate, goods, works or services similar to those undelivered,

and the supplier shall be liable to the purchaser for any excess costs for

such similar goods, works or services. However, the supplier shall

continue performance of the contract to the extent not terminated.

23.3 Where the purchaser terminates the contract in whole or in part, the

purchaser may decide to impose a restriction penalty on the supplier by

prohibiting such supplier from doing business with the public sector for a

period not exceeding 10 years.

23.4

If a purchaser intends imposing a restriction on a s

upplier or any

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 44

12

person associated with the supplier, the supplier will be allowed a time

period of not more than fourteen (14) days to provide reasons why the

envisaged restriction should not be imposed. Should the supplier fail to

respond within the stipulated fourteen (14) days the purchaser may regard

the intended penalty as not objected against and may impose it on the

supplier.

23.5 Any restriction imposed on any person by the Accounting Officer /

Authority will, at the discretion of the Accounting Officer / Authority,

also be applicable to any other enterprise or any partner, manager,

director or other person who wholly or partly exercises or exercised or

may exercise control over the enterprise of the first-mentioned person,

and with which enterprise or person the first-mentioned person, is or was

in the opinion of the Accounting Officer / Authority actively associated.

23.6 If a restriction is imposed, the purchaser must, within five (5) working

days of such imposition, furnish the National Treasury, with the

following information:

(i) the name and address of the supplier and / or person restricted by the

purchaser;

(ii) the date of commencement of the restriction

(iii) the period of restriction; and

(iv) the reasons for the restriction.

These details will be loaded in the National Treasury’s central database

of suppliers or persons prohibited from doing business with the public

sector.

23.7 If a court of law convicts a person of an offence as contemplated in

sections 12 or 13 of the Prevention and Combating of Corrupt Activities

Act, No. 12 of 2004, the court may also rule that such person’s name be

endorsed on the Register for Tender Defaulters. When a person’s name

has been endorsed on the Register, the person will be prohibited from

doing business with the public sector for a period not less than five years

and not more than 10 years. The National Treasury is empowered to

determine the period of restriction and each case will be dealt with on its

own merits. According to section 32 of the Act the Register must be

open to the public. The Register can be perused on the National Treasury

website.

24. Anti-dumping

and countervailing

duties and rights

24.1 When, after the da

te of bid, provisional payments are required, or anti-

dumping or countervailing duties are imposed, or the amount of a

provisional payment or anti-dumping or countervailing right is

increased in respect of any dumped or subsidized import, the State is

not liable for any amount so required or imposed, or for the amount of

any such increase. When, after the said date, such a provisional

payment is no longer required or any such anti-dumping or

countervailing right is abolished, or where the amount of such

provisional payment or any such right is reduced, any such favourable

difference shall on demand be paid forthwith by the contractor to the

State or the State may deduct such amounts from moneys (if any)

which may otherwise be due to the contractor in regard to supplies or

services which he delivered or rendered, or is to deliver or render in

terms of the con

tract or any other contract or any other amount which

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 45

13

may be due to him

25. Force

Majeure

25.1 Notwithstanding the provisions of GCC Clauses 22 and 23, the

supplier shall not be liable for forfeiture of its performance security,

damages, or termination for default if and to the extent that his delay in

performance or other failure to perform his obligations under the

contract is the result of an event of force majeure.

25.2 If a force majeure situation arises, the supplier shall promptly notify

the pu

rchaser in writing of such condition and the cause thereof.

Unless otherwise directed by the purchaser in writing, the supplier

shall continue to perform its obligations under the contract as far as is

reasonably practical, and shall seek all reasonable alternative means for

performance not prevented by the force majeure event.

26. Termination

for insolvency

26.1 The purchaser may at any time terminate the contract by giving written

notice to the supplier if the supplier becomes bankrupt or otherwise

insolvent. In this event, termination will be without compensation to

the supplier, provided that such termination will not prejudice or affect

any right of action or remedy which has accrued or will accrue

thereafter to the purchaser.

27. Settlement of

Disputes

28. Limitation of

liability

27.1 If any dispute or difference of any kind whatsoever arises between the

purchaser and the supplier in connection with or arising out of the

contract, the parties shall make every effort to resolve amicably such

dispute or difference by mutual consultation.

27.2 If, after thirty (30) days, the parties have failed to resolve their dispute

or difference by such mutual consultation, then either the purchaser or

the supplier may give notice to the other party of his intention to

commence with mediation. No mediation in respect of this matter may

be commenced unless such notice is given to the other party.

27.3 Should it not be possible to settle a dispute by means of mediation, it

may be settled in a South African court of law.

27.4 Mediation proceedings shall be conducted in accordance with the rules

of procedure specified in the SCC.

27.5 Notwithstanding any reference to mediation and/or court proceedings

herein,

(a) the parties shall continue to perform their respective obligations

under the contract unless they otherwise agree; and

(b) the purchaser shall pay the supplier any monies due the supplier.

28.1 Except in cases of criminal negligence or willful misconduct, and in

the case of infringement pursuant to Clause 6;

(a) the supplier shall not be liable to the purchaser, whether in

contract, tort, or otherwise, for any indirect or consequential loss

or damage, loss of use, loss of production, or loss of profits or

interest costs, provided that this exclusion shall not apply to any

obligation of the supplier to pay penalties and/or damages to the

purchaser; and

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 46

14

(b) the aggregate liability of the supplier to the purchaser, whether

under the contract, in tort or otherwise, shall not exceed the total

contract price, provided that this limitation shall not apply to the

cost of repairing or replacing defective equipment.

29. Governing

language

29.1 The contract shall be written in English. All correspondence and other

documents pertaining to the contract that is exchanged by the parties

shall also be written in English.

30. Applicable

law

30.1 The contract shall be interpreted in accordance with South African

laws, unless otherwise specified in SCC.

31. Notices

31.1 Every written acceptance of a bid shall be posted to the supplier

concerned by registered or certified mail and any other notice to him

shall be posted by ordinary mail to the address furnished in his bid or

to the address notified later by him in writing and such posting shall be

deemed to be proper service of such notice

31.2 The time mentioned in the contract documents for performing any act

after such aforesaid notice has been given, shall be reckoned from the

date of posting of such notice.

32. Taxes and

duties

32.1 A foreign supplier shall be entirely responsible for all taxes, stamp

duties, license fees, and other such levies imposed outside the

purchaser’s country.

32.2 A local supplier shall be entirely responsible for all taxes, duties,

license fees, etc., incurred until delivery of the contracted goods to

the purchaser.

32.3 No contract shall be concluded with any bidder whose tax matters are

not in order. Prior to the award of a bid the Department must be in

possession of a tax clearance certificate, submitte

d by the bidder.

This certificate must be an original issued by the South African

Revenue Services.

33. National

Industrial

Participation (NIP)

Programme

34 Prohibition of

Restrictive practices

33.1 The NIP Programme administered by the Department of Trade and

Industry shall be applicable to all contracts that are subject to the

NIP obligation.

In terms of section 4 (1) (b) (iii) of the Competition Act No. 89 of 1998, as

amended, an agreement between, or concerted practice by, firms, or a

decision by an association of firms, is prohibited if it is between parties in a

horizontal relationship and if a bidder (s) is / are or a contractor(s) was /

were involved in collusive bidding (or bid rigging).

34.2 If a bidder(s) or contractor(s), based on reasonable grounds or evidence

obtained by the purchaser, has / have engaged in the restrictive practice

referred to above, the purchaser may refer the matter to the Competition

Commission for investigation and possible imposition of administrative

penalties as contemplated in the Competition Act No. 89 of 1998.

34.3 If a bidder(s) or contractor(s), has / have been found guilty by the

Competition Commission of the restrictive practice referred to above, the

purchaser may, in addition and without prejudice to any other remedy

provided for, invalidate the bid(s) for such item(s) offered, and / or

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 47

15

terminate the contract in whole or part, and / or restrict the bidder(s) or

contractor(s) from conducting business with the public sector for a period

not exceeding ten (10) years and / or claim damages from the bidder(s) or

contractor(s) concerned.

Js General Conditions of Contract (revised July 2010)

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 48

S

PLEA

S

SP

E

S

UPPLY A

N

DEVI

C

S

E NOTE:

E

CIAL RE

Q

N

D DELIV

E

C

ES TO T

H

B

C

AN ERRA

N

O

Q

UIREMEN

H

E

RY OF S

M

H

E DEPA

R

01 MAY

2

B

ID VALI

D

C

LOSING

D

24 J

U

TUM WIL

L

TO 2

8

O

BRIEFIN

G

TS AND C

H

P06-2021

M

ALL VOL

U

R

TMENT O

2

021 TO 3

0

D

ITY PERI

O

D

ATE AN

D

U

LY 2020

A

L

BE PUBL

8

SEPTEM

B

G

SESSIO

N

ONDITIO

N

SVP

U

ME PAR

E

F HEALT

H

0

APRIL 2

0

O

D: 120 D

A

D

TIME OF

A

T 11H00

ISHED TO

B

ER 2020

N

WILL BE

N

S OF CO

N

E

NTERAL

S

H

FOR THE

0

24

A

YS

BID:

AMEND

T

HELD.

N

TRACT

S

AND INS

PERIOD

T

HE CLOS

I

ULIN

I

NG DATE

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 50

TABLE

1. LEGI

S

10. LAT

E

11. COU

N

12. FRO

N

13. SUP

P

14. COM

15. CON

T

16. CON

T

17. PAR

T

18. REG

I

19. POS

T

2. BID I

N

20. AW

A

21 NEG

O

22. NON

-

23. PRI

C

23.1 ELI

G

23.2 PRI

C

23.3 AP

P

23.4 RO

U

23.5 EX

C

23.6 PRI

C

24. QUA

L

25. DELI

V

26. SUP

P

27. PAC

K

28 SHE

L

29. CED

I

3. EVAL

U

3.1 PHA

S

3.1.1 LE

G

3.1.2 RE

S

3.1.3 BI

D

3.1.4 AU

T

3.1.5 TA

X

30. THI

R

4. PHAS

E

4.2 COM

5. PHAS

E

6. PREF

E

7. VALU

E

8. SUB

M

9. COM

P

ABBRE

V

BID DO

C

SECTIO

N

SECTIO

N

SECTIO

N

S

OF CONTE

N

S

LATIVE AND

E

BIDS ............

N

TER CONDI

T

N

TING ............

P

LIER DUE DI

L

MUNICATION

T

ACT DETAIL

S

T

RACT PERIO

T

ICIPATING A

U

I

STRATION O

N

T

AWARD PA

R

N

FORMATION

S

A

RD CONDITIO

O

TIATIONS .....

-

COMMITMEN

T

C

E REVIEW .....

G

IBILITY REL

A

C

E ADJUSTM

E

P

LICATION FO

U

TINE PRICE

A

C

EPTIONAL P

R

C

E ADJUSTM

E

L

ITY ..............

V

ERY AND Q

U

P

LIER PERFO

R

K

AGING, LAB

E

L

F LIFE ...........

I

NG, MERGER

S

U

ATION CRIT

E

S

E II: MANDA

T

G

ISLATIVE R

E

S

PONSIVE BI

D

RESPONSE

D

T

HORISATIO

N

X

COMPLIAN

C

R

D PARTIES ...

E

III: PRODUC

T

PLIANCE WIT

H

E

IV: PREFER

E

RENCE FOR

E

ADDED TAX

M

ISSION OF BI

D

P

LETION OF D

O

V

IATIONS .......

C

UMENT CHE

C

N

A

................

N

B ................

N

C ................

S

pecial Req

u

N

TS

REGULATOR

Y

.....................

.

T

IONS ............

.

.....................

.

L

IGENCE .......

.

.....................

.

S

...................

.

O

D ..................

.

U

TORITIES A

N

DATABASE

S

R

TICIPATION .

.

S

ESSION .......

.

NS ................

.

.....................

.

T

...................

.

.....................

.

A

TING TO RA

T

E

NTS RELATI

N

R CONTRACT

A

DJUSTMENT

S

R

ICE ADJUST

M

E

NTS BASED

O

.....................

.

U

ANTITIES .....

.

R

MANCE MAN

E

LLING AND

B

.....................

.

S

, TAKE OVE

R

E

RIA ..............

.

T

ORY REQUIR

E

QUIREMENT

S

D

S .................

.

D

OCUMENT ...

.

N

DECLARATI

O

C

E STATUS ....

.

.....................

.

T

TECHNICAL

H

SPECIFICA

T

E

NCE POINT

S

LOCALLY PR

O

.....................

.

D

S .................

.

O

CUMENTS A

N

.....................

.

C

K LIST .........

.

.....................

.

.....................

.

.....................

.

u

irements a

n

Y

FRAMEWOR

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

N

D OTHER HE

A

S

OF PARTICI

P

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

T

E OF EXCHA

N

G TO FOREI

G

UAL PRICE A

D

S

...................

.

M

ENTS ...........

.

O

N A SYSTEM

.

.....................

.

.....................

.

AGEMENT.....

.

B

ARCODES ....

.

.....................

.

R

S AND CHAN

G

.

.....................

.

E

MENTS ........

.

S

TO THIS BID

.

.....................

.

.....................

.

O

N .................

.

.....................

.

.....................

.

COMPLIANC

E

T

IONS ............

.

S

YSTEM .........

.

O

DUCED PRO

D

.

.....................

.

.....................

.

N

D BID SUBM

I

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

n

d Condition

s



K ...................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

A

LTH ESTABL

P

ATING AUTH

O

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

N

GE ADJUST

M

G

N EXCHANG

E

D

JUSTMENTS

.

.....................

.

.....................

ATIC REVIEW

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

G

ES IN SUPP

L

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

E

....................

.

.....................

.

.....................

D

UCTS ...........

.

.....................

.

.....................

I

SSION ...........

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

s

of Contract

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

IHSMENT ......

.

O

RITIES .........

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

M

ENTS ...........

.

E

RISK ...........

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

L

IER DETAILS

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

: HP06-2021

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

SVP

Page 2

o

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

.

.....................

o

f 38

.................. 7

................ 18

................ 19

................ 20

................ 21

................ 22

.................. 7

................ 22

................ 25

................ 26

................ 27

................ 28

................ 29

................ 30

................ 31

................ 35

................ 37

.................. 7

.................. 8

.................. 9

................ 10

................ 38

................ 11

................ 13

................ 14

................ 15

................ 17

.................. 3

.................. 4

.................. 7

................ 21

................ 31

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 51

ABBR

E

API

BAC

B-BBEE

CPA

CSD

EAN

EME

GMP

MCC

MHPL

MPC

NDoH

PPPFA

QSE

RoE

SAHPR

A

SARS

SBD

VAT

S

E

VIATIONS

:

Ac

: Bi

: B

r

: C

o

: C

e

: E

u

: E

x

: G

o

: M

: N

a

: Pr

e

: Q

u

: R

a

A

: S

o

: S

o

: S

t

: V

a

S

pecial Req

u

c

tive Pharma

c

d Adjudicatio

n

r

oad-Based B

l

o

ntract Price

A

e

ntral Supplie

r

u

ropean Articl

e

x

empted Micr

o

od Manufact

u

edicines Cont

aster Health

P

aster Procure

m

a

tional Depar

t

e

ferential Pro

c

u

alifying Sma

l

a

te of Exchan

g

o

uth African

H

o

uth African R

e

t

andard Biddi

n

a

lue-

A

dded

T

u

irements a

n

c

eutical Ingred

n

Committee

l

ack Economi

c

A

djustment

r

Database

e

Numbering

o

Enterprise

u

ring Practice

rol Council

P

roducts List

m

ent Catalog

u

t

ment of Healt

h

c

urement Poli

c

l

l Enterprise

g

e

H

ealth Product

s

e

venue Servi

c

n

g Document

T

ax

n

d Condition

s



ient

c

Empowerm

e

u

e

h

c

y Framewor

k

s

Regulatory

A

c

e

s

of Contract

e

nt

k

Act

A

uthority

: HP06-2021SVP

Page 3

o

f 38

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 52

BID D

O

A

ll bid

d

below a

n

Submis

s

All bid

d

Bidders

evaluati

o

Compil

a

Seque

n

1

2

3

4

5

6

7

8

9

10

11

12

S

O

CUMENT C

H

d

ocuments lis

t

n

d the annex

u

s

ion of bid do

c

d

ocuments

m

not complyin

g

o

n

a

tion

n

ce

Ad

m

Co

d

C

L

BS

R

BF

I

PBD

4

SBD

5

TC

P

CS

D

SB

D

PB

D

SB

D

SB

D

BBB

E

S

pecial Req

u

H

ECK LIST

t

ed below mu

s

u

re attached.

c

uments is co

m

ust be signe

d

g

to any of th

e

m

in

d

e

Docum

L

Coveri

n

R

A Bid Sig

n

I Bid/File

4

.1 PBD 4.

1

5

.1 SBD 1:

P

Tax Cl

e

D

CSD R

e

latest a

n

summ

a

D

4 SBD 4:

D

9 PBD9:

D

gender

D

5 SBD5:

T

Progra

m

D

6 SBD 6(

1

BBEE)

E

E Valid B

-

origina

points

u

irements a

n

s

t be sorted,

f

m

pulsory, unl

e

d

.

e

requirement

s

ent Name

n

g Letter

n

ature. Resol

u

Index

1

: Contact De

t

Invitation to b

e

arance Pin Is

s

e

gistration re

p

n

d complete r

e

a

ry report wil

l

Declaration o

f

D

irectors: Cat

e

and disability

T

he National I

m

me

1

): Preferenc

e

-

BBEE certific

a

l) or Sworn A

f

n

d Condition

s



f

iled and sub

m

e

ss it's not ap

p

s

may deeme

u

tion/Authorit

y

t

ails of Bidder

id

s

ued

p

ort -

A

certifie

d

e

port. Note:

l

not be acce

p

f

interest

e

gorisation b

y

ndustrial Parti

e

Points Claim

a

te(certified

c

f

fidavit to clai

m

s

of Contract

m

itted in the

e

p

licable and in

d

d to be non-r

e

y

to sign bid

d

copy of

CSD

p

ted.

y

race,

cipation

ed (B-

c

opy of the

m

preference

: HP06-2021

e

xact compil

a

d

icated as su

c

e

sponsive an

d

N/A Yes

SVP

Page 4

o

a

tion sequenc

e

c

h in the "N/A

"

d

will not be c

No

o

f 38

e

as indicated

"

column.

onsidered for

Remark

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 53

Compil

a

Seque

n

13

14

15

16

17

18

19

20

21

22

23

24

S

a

tion

n

ce

Ad

m

Co

d

SB

D

SB

D

PB

D

PBD

1

PBD

1

PB

D

PB

D

CIP

C

N

C

LIC

M

LIC

M

MR

C

S

pecial Req

u

m

in

d

e

Docum

D

8 SBD 8:

D

9 SBD 9:

Determ

i

D

1 PBD1:

A

Note: N

authori

s

may in

v

1

.1 PBD 1.

1

third pa

1

.2 PBD 1.

2

from th

e

D

5 PBD5:

G

Declar

a

D

8 PBD 8:

of Cont

a

C

CIPC/

C

owners

h

registra

C

Proof o

f

change

s

M

I Licenc

e

of the b

Certifi

e

M

Licenc

e

annexu

r

listed o

n

Certifie

d

C

Medici

n

all the

a

Certifie

d

Note:

A

bidder

be sort

u

irements a

n

ent Name

Declaration o

f

Certificate of

ination

A

uthorisation

D

on-complianc

e

s

ation declara

t

v

alidate the bi

d

1

: List of prod

u

rty

2

: Unconditio

n

e

third party.

G

ood Manufa

c

a

tion of compli

a

Special Requ

a

ct. Declarati

o

C

IPRO or proo

f

h

ip/shareholdi

tion certificat

e

f

company ce

d

s

e

to manufact

u

idder), includ

e

d copies req

e

to manufact

u

res for local

m

n

the MRC of

t

d

copies requi

n

e Registratio

n

a

ssociated co

n

d

copies

A

ll MRC's mu

s

with the rele

v

ed and filed i

n

d Condition

s



f

Past SCM P

r

Independent

B

D

eclaration

e

to submissi

o

t

ion, where a

p

d

.

u

cts offered s

o

n

al written und

c

turing Practi

c

a

nce.

irements and

o

n of complia

n

f

of

ng. Certified

c

e

s

d

ings, merger

s

u

re or import (i

ing all annex

uired.

u

re medicines,

m

anufacturin

t

he bidder (a

p

red.

n

Certificates

(

n

ditions of reg

i

s

t be marked

v

ant item nu

m

n numerical

o

s

of Contract

r

actices

B

id

o

n of a valid

p

plicable,

o

urced from

ertaking

c

e (GMP).

Conditions

n

ce.

c

opies of

s

and name

n the name

ures.

including all

g sites as

p

plicant).

(

MRC) with

i

stration -

by the

m

ber and

o

rder.

: HP06-2021

N/A Yes

SVP

Page 5

o

No

o

f 38

Remark

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 54

Compil

a

Seque

n

25

26

27

28

A

Submi

s

The bi

d

be co

m

“

Set 3:

E

S

a

tion

n

ce

Ad

m

Co

d

PI

P

S

BL

PRI

C

A

ll bid docum

e

ssion of supp

o

d

document

m

pleted by

a

E

lectronic v

e

S

pecial Req

u

m

in

d

e

Docum

Origina

l

detailin

g

the Me

d

South

A

uthori

t

Note: A

item nu

m

in num

e

S

Proof o

f

Bidder`

s

C

E Signed

If the E

x

not sig

n

not be

c

e

nts listed abo

o

rting bid doc

u

check

list

i

s

a

ll bidde

r

s a

e

rsion of bid

d

u

irements a

n

ent Name

l

Package Ins

e

g

professional

d

icines Contr

o

A

frican Health

t

y (SAHPRA)

f

A

ll PI`s must b

e

mber and be

s

e

rical order.

f

sample sub

m

s

item list (Li

s

Excel Bid Re

s

x

cel Bid resp

o

n

ed in the spa

c

onsidered fo

r

o

ve must be s

o

u

ments is co

m

s

available

a

nd be sub

m

d

ocuments"

n

d Condition

s



e

rt (PI) or doc

u

information a

o

l Council (MC

Products Reg

f

or each prod

u

e

marked with

s

orted and file

m

ission

s

t of products

o

s

ponse Pricin

g

o

nse Pricing S

c

e provided, t

h

r

evaluation.

o

rted, filed an

d

m

pulsory, unle

s

colum

n

a

s Annexur

e

m

itted in har

d

s

of Contract

u

ment

pproved by

C) or the

ulatory

u

ct offered.

the relevant

d/submitted

o

ffered)

g

Schedule

c

hedule is

h

e bid will

d

submitted in

s

s it's not appl

n

e

A in an ex

c

d

copy and

: HP06-2021

N/A Yes

the exact ord

e

icable and in

d

c

el spreads

h

as part of t

h

SVP

Page 6

o

No

e

r as indicate

d

icated as suc

h

eet format

h

e electroni

o

f 38

Remark

d

above

h

in the "N/A"

and should

c copies of

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 55

SECTI

O

1. LE

G

Thi

s

(Ac

t

(Ac

t

in t

e

are

Co

n

2. BI

D

A

s

t

200

It is

allo

w

3. EV

A

Th

e

P

h

M

a

re

q

C

o

an

d

S

O

N A

G

ISLATIVE

A

s

bid and all c

o

t

101 of 1965)

t

194 of 1993)

e

rms of the P

u

supplementa

r

n

tract are in c

o

D

INFORMA

T

t

he National

D

2, published i

n

strongly rec

o

w

the respon

s

A

LUATION

C

e

evaluation p

r

h

ase I

a

ndatory and

q

uirements

o

mpliance wit

h

d

other bid re

q

S

pecial Req

u

A

ND REGU

L

o

ntracts ema

n

, Pharmacy A

c

; General Co

n

u

blic Finance

M

r

y to General

C

o

nflict with the

T

ION SESSI

O

D

epartment of

n

the Gazette

o

mmended th

a

s

e to reach th

e

C

RITERIA

r

ocess will be

c

other bid

h

mandatory

q

uirements

u

irements a

n

L

ATORY FR

A

n

ating there fr

o

c

t, (Act 53 of

1

n

ditions of Co

n

M

anagement

A

C

onditions of

C

General Con

d

O

N

Health compli

e

18 March 20

2

a

t all prospect

e

bidders befo

r

c

onducted in

p

Phase II

Product te

c

compliance

Compliance

specification

Test reports

sample eval

u

n

d Condition

s



A

MEWORK

o

m will be sub

j

1

974); Patent

s

n

tract issued i

n

A

ct, 1999 (Act

C

ontract (GC

C

d

itions of Con

t

e

s with the re

g

2

0 no briefing

s

ive bidders s

u

r

e the tender

c

p

hases as foll

o

c

hnical

with technical

s

received fro

m

u

ation

s

of Contract

j

ect to the Me

d

s

Act, 1978 (A

c

n

accordance

1 of 1999). T

h

C

). Where, ho

w

t

ract, the Spe

c

g

ulations mad

s

ession or pu

u

bmit all enqui

c

loses.

o

ws:

Phase III

Price an

d

B-BBEE

m

Bids eval

u

terms of t

h

preferenc

e

: HP06-2021

d

icines and R

e

c

t 57 of 1978)

with Treasury

h

e Special C

o

w

eve

r

, the Sp

e

c

ial Condition

s

e under the D

blic bid openi

n

ries to tender

s

P

d

R

a

n

u

ated in

h

e 90/10

e

system

R

a

n

SVP

Page 7

o

e

lated Substa

; Trade Mark

s

Regulation 1

6

o

nditions of C

o

e

cial Conditio

n

s

of Contract

p

isaster Mana

g

n

g will be hel

d

s

@health.gov.

hase IV

R

ecommenda

t

n

d Award

R

ecommendati

n

d award

o

f 38

nces Act,

s

Act, 1993

6

A published

o

ntract (SCC)

n

s of

p

revail.

g

ement Act,

d

.

za on time to

t

ion

on

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 56

3.1

.

S

PHASE I:

Bidders m

u

and time o

f

document

s

comply wit

.

1 LEGISL

A

Items offe

r

1965 (Act

1

contract.

A certifie

d

the Medici

n

items offer

The bidde

r

The bidde

r

in terms o

f

including

a

the produ

c

The bidde

r

medicines,

also be th

e

Where an

i

Related S

u

Bidders m

u

Marks Act,

S

pecial Req

u

MANDATO

R

u

st submit all

r

f

the bid. Duri

n

s

submitted u

n

h all mandato

r

A

TIVE REQU

I

r

ed must be r

e

1

01 of 1965),

d

copy of the

o

n

es and Relat

ed.

r

must be indi

c

r

offering a pr

o

f

section 22C

(

a

ll annexures.

c

t.

r

offering a pr

o

,

including all

a

e

applicant.

i

tem offered i

s

u

bstances Act

u

st comply wi

t

1993 (Act 19

4

u

irements a

n

R

Y REQUIR

E

r

equired docu

m

n

g this evalua

n

der mandato

r

y requiremen

I

REMENTS

T

e

gistered in te

r

and must co

m

o

riginal Medic

i

ed Substance

c

ated as the a

p

o

duct must be

(

1) (b) of the

M

A certified c

o

duct must su

b

a

nnexures for

s

not eligible f

o

, 1965 (Act 1

0

t

h the require

m

4

of 1993). W

h

n

d Condition

s



E

MENTS

m

ents indicat

e

tion phase, bi

d

r

y requiremen

t

ts will be disq

u

T

O THIS BI

D

r

ms of section

m

ply with the c

o

i

ne Registrati

o

e

s Act, 1965 (

A

pplicant on th

e

the holder of

a

M

edicines and

o

py of the ori

g

b

mit a certifi

e

local manufa

c

o

r registeratio

n

0

1 of 1965), a

p

m

ents of the P

h

ere applicabl

s

of Contract

e

d above with

d

der’s respon

s

t

s. This phase

u

alified.

D

15 of the Me

d

o

nditions of r

e

o

n Certificate,

A

ct 101 of 196

e

Medicines

R

a

licence to m

Related Sub

s

g

inal licence

m

e

d copy of the

c

turing sites li

s

n

in terms of s

package inse

r

atents Act, 1

9

e, an explana

: HP06-2021

the bid docu

m

s

es will be ev

a

is not scored

d

icines and R

e

gistration for

t

issued in ter

m

5), must be in

R

egistration C

e

anufacture or

s

tances Act, 1

9

m

ust be submi

t

original licen

s

ted on the M

R

ection 15(3) (

a

r

t of the item

m

9

78 (Act 57 of

tion for any n

o

SVP

Page 8

o

m

ents at the cl

a

luated based

and bidders

w

e

lated Substa

n

t

he duration o

f

m

s of section 1

cluded with th

e

rtificate.

import medici

9

65 (Act 101

o

t

ted by the bi

d

ce to manufa

c

R

C of the bid

d

a

) of the Medi

c

m

ust be suppli

e

1978) and th

e

o

n-complianc

e

o

f 38

osing date

on the

w

ho fail to

n

ces Act,

f

the

5(3) (a) of

h

e bid for all

i

nes issued

o

f 1965)

d

der offering

c

ture

d

er who must

c

ines and

e

d.

e

Trade

e

must be

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 57

3.1

.

3.1

.

3.1

.

S

provided. I

holder of s

patent hol

d

.

2 RESPON

S

Bidders ar

e

All prices

bid docum

e

Response

.

3 BID DOC

U

Bidders ar

and item q

The excel

b

disability p

without ch

a

The prices

All prices

The bid pri

specificati

o

Prices sub

VAT.

.

4 AUTHOR

Only the h

o

Substance

S

pecial Req

u

n the case w

h

uch a product

d

er must be s

u

S

IVE BIDS

e

required to

s

must be sub

m

e

nt. In this re

g

Document” e

x

U

MENTS

e required to

uestionnaires

.

b

id response

d

rovided forms

a

nging the str

u

quoted must

must be sub

m

ce offered for

o

n and the uni

t

mitted must n

o

ISATION D

E

o

lder of a Me

d

s Act, 1965 (

A

u

irements a

n

h

ere a product

, a letter auth

o

u

bmitted with

t

s

ubmit respon

s

m

itted with 2

g

ard, bidder’s

a

x

plaining the

d

submit respo

.

d

ocuments i.e

an integral p

a

u

cture thereof

be furnished

a

m

itted with t

w

a product is

d

t specified.

o

t exceed the

E

CLARATIO

N

d

icines Regist

r

A

ct 101 of 196

n

d Condition

s



is manufactu

r

o

rising the ma

t

he bid.

s

ive bids by c

o

(two) decim

a

ttention is dr

a

d

ifferent fields

nsive bids by

e

. pricing sche

d

a

rt of the bid d

.

A

ll pages m

u

a

s all inclusiv

e

w

o (2) decim

a

d

eemed to be

f

ex-manufact

u

N

r

ation Certific

a

5), may subm

s

of Contract

r

ed under a v

o

rketing of the

o

mpleting all t

a

ls. Docume

n

a

wn to the do

c

in the bid doc

u

completing

a

d

ule and Dire

c

ocument and

u

st be signed.

e

(incl. VAT) o

n

a

ls.

f

or the pack si

u

rer compone

n

a

te issued in t

e

it a bid.

: HP06-2021

o

luntary licens

product, provi

he prices in t

h

n

t and respon

s

c

ument “Defin

ument.

a

ll the prices,

c

tors: Catego

r

bidders must

n

the basis of

ze as adverti

s

n

t of the Singl

e

rms of the M

e

SVP

Page 9

o

e issued by t

h

ded to the bid

h

e Excel Bid

R

s

e fields in th

e

ition of fields i

mandatory re

s

r

isation of rac

e

ensure that it

supply and d

e

s

ed in the ite

m

e

Exit Price in

c

e

dicines and

R

o

f 38

h

e patent

der by the

R

esponse.

e

fillible PDF

n the Bid

s

ponse fields

e

, gender and

is completed

e

livery.

m

c

lusive of

R

elated

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 58

3.1

.

S

In the eve

n

external th

mutually a

g

Where a t

h

A

uthorisati

The Natio

n

the Author

i

Departme

n

Failure to

s

accordanc

e

No agree

m

Health.

.

5 TAX CO

M

The Centr

a

the tax co

m

Certificate

s

Tax Clear

a

It is a con

d

satisfactor

y

It is a requ

an on-goin

submitting

Bidders ar

e

their bid t

h

the suppli

e

S

pecial Req

u

n

t that the Ma

n

ird parties, th

e

g

reed upon b

e

h

ird party is in

v

on Declaratio

n

al Departme

n

i

sation Declar

a

n

t of Health wi

s

ubmit a duly

c

e

with the ab

o

m

ent between

t

M

PLIANCE

S

a

l Supplier Da

t

m

pliance statu

s

anymore b

u

a

nce Certifica

t

d

ition of this bi

d

y

arrangemen

t

irement that b

g basis durin

g

this bid, such

e

required to

b

h

eir Master R

e

r's tax status

o

u

irements a

n

ufacturer, Pa

e

bidder must

e

tween the bi

d

v

olved in any

c

n

(PBD1) for

e

n

t of Health re

s

a

tion and, sh

o

ll exercise an

y

c

ompleted an

d

o

ve provisions

,

t

he bidder an

d

S

TATUS

tabase and th

s of a bidder.

u

t has introdu

c

t

es which the

y

d

that the tax

m

ts have been

m

idders grant

a

g

the tenure o

f

confirmation

i

b

e registered

o

e

gistration N

u

o

n the Centra

n

d Condition

s



cker or other

e

ensure that al

d

der and thes

e

c

apacity, the

b

e

ach such thir

d

s

erves the rig

h

o

uld the infor

m

y

of the reme

d

signed Auth

o

,

will invalidat

e

d

any third pa

r

e tax complia

n

The South Af

r

c

ed an online

y

can submit

w

matters of the

made with S

A

a

written confir

f

the contract,

i

s deemed to

h

o

n the Gover

n

u

mber (Supp

l Supplier Dat

a

s

of Contract

e

ntity, as liste

d

l legal, financi

e

third parties.

b

idder must s

u

d

party.

h

t to verify an

y

m

ation be foun

d

ies available

t

o

risation Decl

a

e

the bid for s

u

r

ty will be bind

n

ce status PI

N

r

ican Revenu

e

provision via

w

ith their bids

o

bidder be in

o

A

RS to meet t

h

mation when

s

disclose the

b

h

ave been gr

a

n

ment's Cent

r

lier Number)

a

base;.

: HP06-2021

d

on the certifi

al and supply

u

bmit a duly c

o

y

information

s

d

to be false

o

t

o it in the bid

a

ration, with t

h

u

ch goods or

s

ing on the Na

t

N

are the app

r

e

Service doe

eFiling, for bi

d

o

r price quota

o

rder at any p

o

h

e bidder’s tax

s

ubmitting thi

s

b

idder’s tax co

a

nted.

r

al Supplier

D

in order to en

a

SVP

Page 10

o

i

cate of regist

r

arrangement

s

o

mpleted and

s

upplied by th

e

o

r incorrect, th

e

documents.

h

e required a

n

s

ervices offer

e

t

ional Depart

m

r

oved method

s

s not issue T

a

d

ders to print

tions.

o

int in time, o

r

obligations.

s

bid that SA

R

mpliance stat

u

D

atabase and

a

ble the instit

u

o

f 38

r

ation are

s

have been

signed

e

bidder in

e

National

n

nexure(s), in

e

d.

m

ent of

s

of verifying

a

x Clearance

their own

r

that

R

S may, on

u

s and, by

to include in

u

tion to verify

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 59

4

. PH

A

4.1 SA

M

A

ll

b

De

p



Fail

Sa

m

tim

e

S

Foreign s

u

A

frica mus

been mad

e

Revenue

S

Service wi

l

foreign en

t

Should th

e

wull reject

The Natio

n

Where co

n

Supplier D

Bidders re

m

this bid.

A

SE II: PRO

M

PLES TO

B

b

idders are re

q

p

artment of H

e

Compliance

w

Compliance

o

101 of 1965)

ure to submit

m

ples are req

u

e

of bid:

S

pecial Req

u

ppliers with

t complete t

h

e

to a foreign

b

S

ervice to em

a

l

l issue a conf

i

t

ity has tax ob

l

e

recommend

e

the bid submi

t

n

al Departme

n

sortia/joint ve

atabase and t

m

ain responsi

DUCT TEC

H

B

E SUBMIT

T

q

uired to sub

m

e

alth with pro

d

w

ith specifica

t

o

f the produc

t

.

samples at b

o

u

ired to be su

b

u

irements a

n

neither Sout

h

e questionna

i

b

idder, the N

D

a

il address: G

i

rmation of ta

x

l

igations in S

o

e

d bidder fail

t

ted by the bi

d

n

t of Health sh

ntures/sub-co

heir tax comp

l

ble to update

H

NICAL CO

M

T

ED TO HE

A

m

it samples, i

n

d

ucts to confir

m

t

ions as set o

u

t

with the req

u

o

th health est

a

b

mitted to eac

h

n

d Condition

s



h

African tax

ire on the SB

D

OH will sub

m

overnmentlns

t

x

obligations l

e

o

uth Africa

t

o provide writ

d

der.

all verify the

b

ntractors are i

liance status

w

their CSD inf

o

M

PLIANCE

A

LTH ESTA

B

n

cluding bidd

e

m

the followin

g

u

t in the bid d

o

u

irements of t

h

a

blishments li

s

h

(both) of th

e

s

of Contract

obligations

n

D1. Where a

m

it the bidder'

s

titute@sars.g

o

e

tter to the ND

ten proof of t

h

b

idder’s tax co

nvolved, eac

h

w

ill be verified

o

rmation in lin

e

B

LISHMENT

S

e

rs who are cu

g

:

o

cument/item

s

h

e Medicines

s

ted below will

e

addresses in

d

: HP06-2021

n

or history of

recommenda

t

s

completed S

o

v.za. The So

OH, confirmi

n

h

eir tax compli

a

mpliance stat

u

h

party must b

e

through the

C

e

with the bid

d

S

rrently supply

i

s

pecification.

and Related

S

invalidate th

e

d

icated below

SVP

Page 11

o

doing busin

e

t

ion for awar

d

BD1 to the S

o

uth African R

e

n

g whether or

n

a

nce status, t

h

u

s through th

e

registered o

C

entral Suppli

e

d

ocuments s

u

i

ng the Nation

S

ubstances

A

e

bid for such i

t

prior to closi

n

o

f 38

e

ss in South

d

of a bid has

o

uth African

evenue

n

ot the

h

e NDOH

e

CSD.

n the Central

e

r Database.

u

bmitted for

al

A

ct, 1965 (Act

t

ems offered.

n

g date and

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 60

Mr

D

De

p

Tel:

Ga

u

Sto

r

35

P

Hur

s

209

S

D

umisani Mal

e

p

ot Manager

011 628 913

1

u

teng: Medica

l

r

e 3

P

lunkett Aven

u

s

t Hill

2

 No sam

p

 Sample

s

address

.

 Bidders

 It is the

provide

d



A

ll sam

p



A

ll sam

p



A

ll sam

p

approve

d

 Proof o

f

evaluati

o

S

pecial Req

u

e

le

1

l

Supplies De

p

u

e

p

les must be

s

must be m

a

.

must submit

a

responsibilit

y

d

above.

p

les for award

e

p

les must be a

p

les submitte

d

by the MCC

f

sample sub

o

n site, must

b

u

irements a

n

p

ot

s

ent to the Na

t

a

rked with th

e

a

t least one or

i

y

of the bidd

e

d items will b

true represe

n

d

must includ

e

or SAHPRA.

mission, incl

u

b

e submitted

w

n

d Condition

s



t

ional Depart

m

e

bid number,

i

ginal pack of

e

r to ensure

e retained for

n

tation of the

p

e

the package

u

ding a signe

w

ith the bid do

s

of Contract

Mr Nisaar

M

Pharmaceu

t

Tel: 021 48

3

Western Ca

4th Floor, C

a

16 Chiappin

Cape Town

8001

m

ent of Health

.

the item nu

m

e

ach offer for

that samples

the period of

t

p

roduct which

insert or do

c

e

d copy of th

cuments at th

e

: HP06-2021

M

ia

t

ical Policy Sp

3

5800

pe: Departme

a

pe Medical

D

i Street

.

m

ber as well

evaluation.

have been

r

t

he contract.

will be suppli

e

c

ument detaili

n

e item list a

s

e

closing dat

e

SVP

Page 12

o

ecialist

nt of Health

D

epot

as the bidde

r

eceived at t

h

e

d.

n

g profession

a

s

received b

y

e

and time of t

h

o

f 38

r

’s name and

h

e addresses

a

l information

y

the sample

h

e bid.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 61

4.2 CO

Ite

m

5. PH

A

5.1 A

M

5.2 PO

In t

e

aw

a

B-B

Co

n

1

2

3

4

5

6

7

8

Non

For

S

MPLIANCE

W

m

s must comp

l

A

SE IV: PR

E

M

AXIMUM O

F









 180Ps

Where

Ps =

Pt =

Pmin =

INTS AWA

R

e

rms of Regul

a

rded to a bid

d

BEE Status L

e

n

tributor

-compliant con

t

this tender, th

S

pecial Req

u

W

ITH SPEC

l

y with the sp

e

E

FERENCE

P

F

80 OR 90

P

80/20



min

m

i

P

PPt

Points s

c

Price of

b

Price of

l

R

DED FOR B

a

tion 6(2) and

d

er for attainin

e

vel of

t

ributor

e 90/10 prefer

e

u

irements a

n

IFICATION

S

e

cification as

d

P

OINT SYS

T

P

OINTS IS

A







i

n

or

c

ored for pric

e

b

id under con

s

l

owest accept

a

-BBEE STA

T

7(2) of the P

r

g the B-BBE

E

Numbe

r

(

90/10 s

y

e

nce point s

ys

n

d Condition

s



S

d

etailed in the

T

EM

A

LLOCATE

D

or

 9

0

Ps

e

of bid under

c

s

ideration

a

ble bid

T

US LEVEL

r

eferential Pro

E

status level

o

r

of points

y

stem

)

10

9

6

5

4

3

2

1

0

s

tem will be ap

s

of Contract

bid documen

t

D

FOR PRIC

E

90/









m

1

0

P

Pt

c

onsideration

OF CONTRI

curement Re

g

o

f contribution

plied.

: HP06-2021

t

.

E

ON THE F

O

10







m

in

min

P

BUTOR

g

ulations, pref

e

in accordanc

e

Number

o

(

80/20 s

ys

SVP

Page 13

o

O

LLOWING

B

e

rence points

e

with the tabl

e

o

f points

s

tem

)

20

18

14

12

8

6

4

2

0

o

f 38

B

ASIS

:

must be

e

below:

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 62



B

t



T

s



O

s

a

o



E

A



S

p



I

p

N

s

t

c



A

n

6. PR

E

Th

e

req

u

In o

limi

t

me

d

pro

d

S

B

idders are r

e

t

he original B-

t

he B-BBEE s

t

T

he points s

c

s

cored for pri

c

O

nly bidders

w

s

ubmitted a

c

a

ccounting of

f

o

r an accredit

e

E

xempted Mi

c

A

ffidavit as pr

e

S

worn Affida

v

p

rescribed by

I

f the bidder

f

p

reference p

o

N

ational Dep

a

s

ubstantiate

c

t

he nearest t

w

c

ontract will b

e

A

contract m

a

n

umber of poi

n

E

FERENCE

e

National De

p

u

ired to indica

o

rder to provid

e

t

ed to product

d

icines (includ

d

uction of fini

s

S

pecial Req

u

e

quired to co

m

BBEE status l

t

atus level poi

c

ored by a bi

d

c

e.

w

ho have co

m

c

ertified copy

f

icer (as conte

e

d verification

cro Enterpris

e

scribed by th

v

its submitted

the B-BBEE

C

f

ails to comp

l

o

ints for B-B

B

a

rtment of H

c

laims it has

m

w

o (2) decim

a

e

awarded to

t

a

y, on reason

a

n

ts.

FOR LOCA

L

p

artment of H

e

te on the Exc

e

preference t

formulation a

n

ing importatio

s

hed products

)

u

irements a

n

m

plete the pr

e

evel verificati

o

nt.

d

der in respe

c

m

pleted and si

g

of an origin

a

mplated in se

agency will b

e

s (EME’s)

a

e B-BBEE C

o

by EME’s a

n

C

ommission.

l

y with the p

a

B

EE status le

v

ealth may,

b

m

ade with reg

a

ls. In the ev

e

t

he bidder sc

o

a

ble and justi

f

L

LY PRODU

e

alth reserves

e

l Bid Respon

s

o locally prod

u

nd conversio

n

n of raw mate

)

in the Repu

b

n

d Condition

s



e

ference clai

m

o

n certificate,

c

t of the leve

g

ned the decl

a

l B-BBEE s

t

ction 60(4) of

e

considered

f

a

nd Qualifyin

g

o

mmssion, Pr

a

n

d QSE will

s

a

ragraphs ab

o

v

el of contrib

u

b

efore a bid

a

rd to prefere

e

nt that two

(

o

ring the high

e

f

iable ground

s

CED PROD

U

the right to c

o

s

e Document

u

ced product

s

n

processes th

rial of active

p

b

lic of South A

f

s

of Contract

m

form (SBD

6

at the closing

l of B-BBEE

a

ration part of

t

atus level ce

the Close Co

r

f

or preferenc

e

g

Small Ente

a

ctice Guide 0

1

s

trictly be ev

a

o

ve, the bidd

e

u

tion and will

is adjudicate

d

nce claimed.

(

2) or more

b

e

st number of

p

s

, be awarde

d

U

CTS

o

nsider locally

where the pr

o

s

, the definitio

n

at use materi

a

p

harmaceutic

a

f

rica.

: HP06-2021

6

.1), and sub

m

date and tim

e

contribution

w

the preferenc

e

rtificate issue

r

poration Act,

e

points.

rprices (QSE

1

of 2019.

a

luated accor

d

e

r will be de

e

therefore be

d

or at any

The points s

c

b

ids have sco

p

reference po

d

to a bid tha

t

produced pro

d

o

ducts are ma

n

of a locally p

a

ls and comp

o

a

l ingredients (

A

SVP

Page 14

o

m

it a valid ce

r

e

of the bid in

o

w

ill be added

e

claim form

a

d by a regis

t

1984 (Act No

.

’s) must sub

d

ing the the

g

e

med not to

h

allocated a

z

time, require

c

ored will be r

o

red equal tot

a

ints for B-BB

E

t

did not sco

r

e

d

ucts offered.

n

ufactured.

roduced prod

u

o

nents to man

u

API) and of e

x

o

f 38

r

tified copy of

o

rder to claim

to the points

a

nd who have

t

ered auditor,

.

69 of 1984))

mit a Sworn

g

uidelines as

h

ave claimed

z

ero (0). The

a bidder to

o

unded off to

a

l points, the

E

E.

e

the highest

Bidders are

u

ct will be

u

facture

x

cipients for

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 63

Wh

e

ite

m

ne

g

Bid

s



7.

VA

L

A

ll

bid

8.

SU

B

A

ll

b

indi

c

Su

b

in t

h

All

b

S

e

re the Natio

n

m

s will be allo

c

g

atively impa

c

s

for products

The South

A

primary site

o

The bidder o

terms of sec

t

all annexure

s

The bidder o

f

including all

a

applicant.

The referenc

The site/s of

Demonstrate

Excel Bid Re

Previous su

p

Compliance

t

L

UE ADDE

D

bid prices mu

d

.

B

MISSION

O

b

id document

s

c

ated below a

b

mission of bi

d

h

e Bid Docum

e

b

id docume

n

S

pecial Req

u

n

al Departmen

c

ated and aw

a

c

t upon secu

that qualify fo

A

frican Healt

h

o

f production

a

ffering a prod

t

ion 22C (1) (

b

s

. A certified

f

fering a prod

u

a

nnexures fo

r

e price as pu

b

manufacture

a

d capacity to

sponse Docu

m

p

plier perform

a

t

o all other as

p

D

TAX

st be inclusiv

e

O

F BIDS

s

listed below

m

a

nd the annex

u

d

documents i

s

e

nt Check Lis

t

n

ts must be s

i

u

irements a

n

t of Health gi

v

a

rded proporti

o

rity of suppl

y

r this prefere

n

h

Product Au

t

a

s one that is

l

uct must be t

h

b

) of the Medi

c

copy of the

o

u

ct must sub

m

r

local manuf

a

b

lished by Nat

a

nd/or packa

g

service the r

e

m

ent;

a

nce;

p

ects contain

e

of 15% Valu

e

must be sorte

d

u

re attached.

s

mandatory,

u

t

.

i

gned.

n

d Condition

s



v

es preferenc

e

o

nately to loc

a

y

and afforda

b

n

ce must com

p

t

hority (SAHP

located in the

h

e holder of a

c

ines and Rel

a

o

riginal licenc

e

m

it a certified

a

cturing sites l

ional Depart

m

g

ing for the pr

o

e

quired volu

m

e

d in these Sp

e

-

A

dded Tax.

d

, filed and s

u

nless it's not

s

of Contract

e

to locally pro

a

lly produced

p

b

ility.

p

ly with all of t

RA) certificat

e

Republic of S

licence to m

a

ted Substan

c

e

must be sub

m

copy of the o

r

isted on the

M

m

ent of Health

o

duct offered i

s

m

es as evalua

t

ecial Conditio

Failure to co

m

u

bmitted in th

e

applicable an

d

: HP06-2021

duced produc

p

roducts, prov

he following c

e

of registrat

i

outh Africa;

a

nufacture or

c

es Act, 1965

m

itted by the

b

r

iginal licence

M

RC of the bi

d

has not been

s

located in S

o

t

ed in terms

o

ns of Contrac

t

m

ply with this

c

e

exact compil

a

d

indicated as

SVP

Page 15

o

c

ts, the quantit

ided this doe

s

riteria:

i

on for a pro

d

import medici

n

(Act 101 of 1

9

b

idder offering

to manufactu

r

d

der who mu

s

exceeded (if

a

o

uth Africa;

o

f the data pr

o

t

c

ondition will i

n

a

tion sequenc

such in the "

N

o

f 38

ies for these

s

not

d

uct lists the

n

es issued in

9

65) including

the product.

r

e medicines,

s

t also be the

a

pplicable);

ovided in the

n

validate the

c

e as

N

/A" column

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 64

Bid

d

con



S

d

ers not com

sidered for ev

Covering Let

t

Status relati

n

Resolution/A

Bid/File Inde

x

PBD 4.1: Co

n

SBD 1: Invit

a

Tax Clearan

c

CSD Registr

a

be accepted;

SBD 4: Decl

a

PBD9: Direc

t

SBD5: The

N

SBD 6(1): Pr

Valid B-BBE

E

SBD 8: Decl

a

SBD 9: Certi

f

PBD1: Auth

o

where applic

a

PBD 1.1: Lis

t

PBD 1.2: Un

c

PBD5: Good

PBD 8: Spe

c

CIPC/CIPR

O

Proof of com

Certified cop

y

Certified cop

y

listed on the

S

pecial Req

u

plying to an

y

aluation.

ter i.e. limited

n

g to TAX, B-

B

uthority to sig

n

x

;

n

tact Details

o

a

tion to bid;

c

e Pin Issued;

a

tion report -

A

a

ration of inte

r

t

ors: Categori

s

N

ational Indus

t

eference Poi

n

E

certificate (

c

a

ration of Pas

t

f

icate of Inde

p

o

risation Decl

a

ble, may inv

a

t

of products

o

c

onditional wr

i

Manufacturin

g

c

ial Requirem

e

O

or proof of o

w

pany cedings

,

y

of Licence t

o

y

of Licence t

o

MRC of the bi

u

irements a

n

y

of the requ

i

stock availab

i

B

BEE, Licens

e

n

bid;

o

f Bidder;

A

certified co

p

r

est;

s

ation by race

t

rial Participati

n

ts Claimed (B

c

ertified copy)

t

SCM Practic

e

p

endent Bid D

e

a

ration Note:

a

lidate the bid

o

ffered source

d

i

tten undertak

i

g

Practice (G

M

e

nts and Cond

w

nership/shar

e

,

mergers and

o

manufactur

e

o

manufactur

e

dder (applica

n

d Condition

s



i

rements ma

y

i

lity of any ite

m

e

to Manufact

u

p

y of latest an

d

, gender and

d

on Programm

-BBEE);

or Sworn Affi

d

e

s;

e

termination;

Non-complian

;

d

from third p

a

ing from the t

h

M

P). Declarati

itions of Cont

a

e

holding. Cer

t

name chang

e

or import (in

t

e

medicines, i

n

t);

s

of Contract

y

be deemed

m

offered, non

u

re, Certificat

e

d

complete re

p

d

isability;

e;

d

avit to claim

p

ce to submis

s

a

rty;

h

ird party;

on of complia

n

a

ct. Declarati

o

t

ified copies o

f

e

s;

t

he name of t

h

n

cluding all a

n

: HP06-2021

to be non-r

e

-compliance;

e

s etc. Bid Sig

n

p

ort. Note: C

S

p

reference po

i

s

ion of a vali

d

n

ce;

o

n of complian

f

registration

c

h

e bidder), inc

n

nexures for l

o

SVP

Page 16

o

e

sponsive an

d

n

ature;

S

D summary

r

i

nts;

d

authorisatio

n

ce;

c

ertificates;

luding all ann

e

o

cal manufact

u

o

f 38

d

will not be

r

eport will not

n

declaration,

e

xures;

u

ring sites as

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 65



9.

CO

Bid

d

mu

s

and

bid

info

Set

Bid

d

fiel

d

cop

y

Bid

d

Fin

a

S

Certified cop

(Annexure).

N

filed in nume

Original Pac

Control Cou

n

product offe

filed/submitt

e

order;

Proof of sam

Bidder`s ite

m

Signed Exce

l

Bid respons

e

evaluation

MPLETION

O

d

ers are requi

r

s

t be submitte

d

submitted in

a

number and t

h

rmation requ

e

1: Hard cop

y

d

ers must co

m

d

is provided

b

y of the bid d

o

d

ers must sub

a

ncial Officer,

S

pecial Req

u

ies of Medicin

N

ote: All MR

C

rical order;

kage Insert (

P

n

cil (MCC) o

r

red. Note: A

l

e

d in numeric

a

ple submissio

m

list (List of p

r

l Bid Respon

s

e

Pricing Sc

h

O

F DOCUM

E

r

ed to submit

t

d

not later tha

a

sealed pac

k

h

e closing dat

e

sted is not rel

y

legally bind

m

plete all SBD

b

idders must c

o

cument will s

e

mit their com

p

or authorised

u

irements a

n

e Registratio

n

C

's must be m

a

PI) or docum

r

the South

A

l

l PI`s must

a

l

n;

r

oducts offere

d

s

e Pricing Sch

e

h

edule is not

E

NTS AND

B

t

hree sets of

b

n the closing

d

k

age. The full

n

e

must be cle

a

evant this sh

o

ing bid docu

m

, PBD and Bi

d

omplete the f

o

e

rve as the le

g

p

lete bid in ha

r

designee of t

h

n

d Condition

s



n

Certificates

(

a

rked by the b

ent detailing

A

frican Healt

h

be marked

w

d

); and

e

dule (All pric

e

signed in th

e

B

ID SUBMIS

b

id document

s

d

ate and time

.

n

ame and ad

d

a

rly indicated

o

uld be indicat

e

m

ents

d

Response f

o

rms in black i

g

al bid docum

r

d copy forma

t

h

e entity sub

m

s

of Contract

(

MRC) with all

idder with the

professional

i

h

Products R

e

w

ith the rele

v

es must be s

u

e

space provi

d

SION

s

according to

.

Set 2 and S

e

d

ress of the bi

d

o

n the packa

g

e

d with N/A.

o

rms in black i

n

nk, handwritt

e

ent.

t

(paper docu

m

itting the bid

m

: HP06-2021

the associat

e

relevant item

i

nformation a

p

e

gulatory Aut

h

v

ant item nu

m

u

bmitted in 2 (

t

d

ed, the bid

w

the instructio

n

e

t 3 must be in

d

der, includin

g

e. All fields m

n

k, typed. Wh

e

n in capital le

m

ent). The C

h

m

ust sign the

SVP

Page 17

o

e

d conditions

o

number and

b

p

proved by t

h

ority (SAHP

R

m

ber and b

e

t

wo) decimals

will not be c

o

n

s below. All t

h

n

cluded on a

C

g

the return a

d

m

ust be compl

e

re no electro

tters. The sig

n

h

ief Executive

official signat

u

o

f 38

o

f registration

b

e sorted and

h

e Medicines

R

A) for each

e

sorted and

). If the Excel

o

nsidered for

h

ree sets

C

D with Set 1

d

dress, the

e

ted. Where

nic entry

n

ed hard

Officer, Chief

u

re pages.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 66

All

p

not

A

s

t

200

Bid

d

Lat

e

Bid

req

u

tw

o

unt

i

Set

Bid

d

req

u

Set

Bid

d

Do

c

A

ll

t

Bid

d

unit

.

10.

LA

T

Bid

s

for

c

S

p

ages in the c

o

acceptable.

A

t

he National

D

2, published i

n

d

ers must still

e

bids will not

ders must re

f

u

ested that

b

o

hole lever a

r

ied for filing

p

2: PDF of H

a

d

ers must sub

u

ested.

3: Electroni

c

d

ers must sub

c

ument and ot

h

t

hree sets of i

n

d

ers must en

s

pack as spe

c

T

E BIDS

s

received aft

e

c

onsideration

S

pecial Req

u

o

mplete bid d

o

A

ny change/s

m

D

epartment of

n

the Gazette

ensure that b

i

be accepted f

o

f

rain from us

b

idders pre-p

u

r

ch file. Bid

d

p

urposes.

a

rd Copy, sig

n

mit a PDF ve

r

c

version of

b

mit the electr

o

her relevant s

n

formation mu

s

ure that the p

c

ified. No con

v

e

r the closing

d

and, where p

r

u

irements a

n

o

cument mus

t

m

ust be clearl

y

Health compli

e

18 March 20

2

ids are delive

r

o

r considerati

o

ing binding

m

u

nch two hol

e

d

ocuments s

h

n

ed legal do

c

r

sion of the en

b

id document

s

o

nic versions

(

preadsheets i

n

st be submitt

e

rice quoted f

o

v

ersion factor

s

d

ate and time

,

r

actical, be ret

n

d Condition

s



t

be initialed b

y

indicated an

d

e

s with the re

g

2

0 no briefing

s

r

ed on time to

o

n

m

ethods like

c

e

s on the lef

t

h

ould be tied

c

uments. (i.e.

tire signed ha

s

(

editable pdf)

o

n

Excel (not p

d

e

d in order for

o

r a product (l

s

will be appli

e

,

at the addre

s

urned unopen

s

of Contract

y

same with b

d

initialed.

g

ulations mad

s

ession or pu

b

the correct a

d

c

oil, comb,

w

t

hand side o

f

in parcels u

s

pdf of Set 1)

rdcopy bid, in

c

o

f all SBD an

d

f).

the bid to be

e

ine item) on t

h

e

d.

s

s indicated in

ed to the bidd

: HP06-2021

lack ink. The

u

e under the D

b

lic bid openi

n

d

dress and de

p

w

ire velobind,

f

bid docume

s

ing string or

c

luding all cer

t

d

PBD docum

e

valuated.

h

e Bid Respo

n

the bid docu

m

er.

SVP

Page 18

o

u

se of correct

i

isaster Mana

g

n

g will be held

.

p

osited in the

screw bindi

n

nts suitable

f

rope that ca

n

t

ificates and d

e

nts, Bid Res

p

n

se Documen

t

m

ents, will not

o

f 38

i

on fluid is

g

ement Act,

.

However,

Tender Box.

n

g etc. It is

f

or filing in a

n

be easily

ocuments

p

onse

t

is for the

be accepted

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 67

11.

CO

Bid

d

con

12.

FR

O

Th

e

rec

o

the

m

co

m

Th

e

par

t

acc

u

Gui

d

Ind

u

fro

n

bid/

sec

t

aga

13.

SU

P

Th

e

any

the

14.

CO

Th

e

and

S

UNTER CO

N

d

ers’ attention

ditions by bid

d

O

NTING

e

National De

p

o

gnises that r

e

m

selves in ac

c

m

pliant manne

r

e

National De

p

t

of the bid ev

a

u

racy of the r

e

d

elines on Co

u

stry, be esta

b

n

ting does not

contract and

t

or for a perio

d

inst the bidde

r

P

PLIER DU

E

e

National De

p

time during t

h

site specified

MMUNICAT

I

e

National De

p

time of the bi

S

pecial Req

u

N

DITIONS

is drawn to t

h

d

ers may resu

p

artment of H

e

al empower

m

c

ordance with

r

. Against this

p

artment of H

e

a

luation proce

e

presentation

mplex Structu

b

lished during

exist. Failure

t

may also res

u

d

not exceedi

n

r

/contractor c

o

E

DILIGENC

E

p

artment of H

e

h

e contract pe

in the bid and

I

ON

p

artment of H

e

d and prior to

u

irements a

n

h

e fact that a

m

lt in the invali

d

e

alth support

s

m

ent can only

b

the Constituti

o

background,

t

e

alth, in ensuri

sses, conduc

t

made in bid d

o

res and Tran

s

such enquiry

/

t

o do so withi

n

u

lt in the restri

c

n

g 10 years, i

n

o

ncerned.

E

e

alth reserves

riod. This ma

the site com

p

e

alth, may co

m

the award of

t

n

d Condition

s



m

endments to

a

d

ation of such

s

the spirit of b

b

e achieved t

h

o

n and in an

h

t

he National

D

ng that bidde

r

t

or initiate the

o

cuments. Sh

s

actions and

F

/

investigation,

n

a period of 1

c

tion of the bi

d

n

addition to a

n

the right to c

o

y include site

p

lies with quali

m

municate wit

h

t

he contract,

o

s

of Contract

a

ny of the bid

bids.

road based bl

h

rough individ

u

h

onest, fair, e

q

D

epartment of

r

s conduct the

necessary e

n

ould any of th

e

F

ronting, issue

the onus will

b

4 days from d

d

der/contract

o

n

y other reme

o

nduct supplie

r

visits to asse

s

i

ty criteria.

h

bidders whe

o

r to extend th

e

: HP06-2021

conditions or

ack economi

c

u

als and busi

n

q

uitable, trans

p

Health conde

m

mselves in an

n

quiries/invest

e

fronting indi

c

d by the Dep

a

b

e on the bid

d

ate of notifica

t

o

r to conduct

b

dies the Nati

o

r

due diligenc

e

s

s whether an

re clarity is so

e

validity peri

o

SVP

Page 19

o

setting of cou

c

empowerme

n

esses condu

c

p

arent and le

g

m

ns any form

honest mann

igations to de

t

c

ators as con

t

a

rtment of Tra

d

er/contractor

t

ion, may inv

a

b

usiness with

t

o

nal Treasury

m

e

prior to final

item is manu

f

ught after the

o

d of the bid, i

f

o

f 38

nter

n

t and

c

ting

g

ally

of fronting.

er will, as

t

ermine the

t

ained in the

d

e and

t

o prove that

a

lidate the

t

he public

m

ay have

award or at

f

actured at

closing date

f

necessary.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 68

A

n

y

De

p

dis

c

A

ll

c

15. CO

P

o

D

P

r

P

R

0

Pl

e



S

y

communicati

o

p

artment of H

e

c

ouraged.

c

ommunicatio

n

NTACT DE

T

o

stal addres

s

irectorate: Aff

o

r

ivate Bag X8

2

R

ETORIA

0

01

e

ase use the

f

tenders@h

e

S

pecial Req

u

o

n to any gov

e

alth in respe

c

n

between th

e

T

AILS

s

o

rdable Medi

c

2

8

f

ollowing e-m

a

e

alth.gov.za

u

irements a

n

e

rnment offici

a

c

t of this bid b

e

bidder and t

h

c

ines

a

il address for

n

d Condition

s



a

l or a person

e

tween the cl

o

h

e National D

e

any queries r

e

s

of Contract

acting in an

a

o

sing date and

e

partment of

H

Physical a

d

Directorate:

Civitas Buil

d

242 Struben

Cnr Thabo

S

Pretoria

0002

e

lating to bidd

: HP06-2021

a

dvisory capa

c

the award of

H

ealth, must b

e

d

dress

Affordable M

e

d

ing

Street

S

ehume Stree

t

ing process:

SVP

Page 20

o

c

ity for the Na

t

the bid by the

e

done in writi

e

dicines

t

o

f 38

t

ional

bidder is

ng.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 69

SECT

I

16.

C

T

17.

P

N

P



O



18.

R

A

a

f

F

S

I

ON B

C

ONTRACT

P

he contract s

h

P

ARTICIPAT

I

articipating A

u

N

ational Depar

rovincial Dep

a

Eastern C

a

Free State

Gauteng;

KwaZulu-

N

Limpopo.

O

ther Institutio

n

Nelson M

a

R

EGISTRATI

O

A

ll contracted

s

f

ter award of

c

ailure to meet

S

pecial Req

u

P

ERIOD

h

all be for the

I

NG

A

UTHO

u

thorities and

tments, Provi

n

a

rtments:

a

pe;

;

N

atal;

n

s:

a

ndela Childre

n

O

N ON DAT

A

s

uppliers mus

t

c

ontract.

this requirem

u

irements a

n

period from 0

1

RITES AND

Health Establ

i

n

cial Departm

e

n

s' Hospital

A

BASES O

F

t

register on t

h

ent will result

n

d Condition

s



1

May 2021 t

o

OTHER HE

A

i

shments whi

c

e

nts and orth

e

F

PARTICIP

A

h

e supplier d

a

in the inability

s

of Contract

o

30

A

pril 202

4

A

LTH ESTA

B

c

h will be parti

c

e

r institutions

a

 M

p

 N

o

 N

o

 W

A

TING AUT

H

a

tabases of P

a

to process p

a

: HP06-2021

4

.

B

LISHMENT

c

ipating auth

o

a

s approved

b

p

umalanga;

o

rthern Cape;

o

rth West;

estern Cape;

a

H

ORITIES

a

rticipating

A

u

t

a

yment for go

o

SVP

Page 21

o

S

o

rities in this c

o

b

y the account

a

nd

t

horities withi

n

o

ds.

o

f 38

o

ntract are

ing officer.

n

30 days

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 70

Page 22

o

19.

P

R

P

A

e

n

o

f

20.

A

T

s

a

T

c

o

T

a

w



I

n

D

p

a

n

o

s

i

t

h

o

f 38

P

OST AWAR

R

egulation 16

A

ublic Entities,

A

ccounting Off

i

n

tity, request

t

f

state, subje

c

A

WARD CO

N

he National D

a

me item.

he National D

o

ntractors (tw

o

he following a

w

ard:



Source

o



Capacit

y



Estimat

e



Risk to

p



Past co

m

n

cases where

D

epartment of

a

ck sizes suit

a

o

conversion

f

i

zes during ev

h

at specified i

s

Sp

e

D PARTICI

P

A

6.6 of the Tr

e

issued in ter

m

i

cer/Accounti

n

t

o participate i

c

t to the writte

n

N

DITIONS

epartment of

H

epartment of

H

epartment of

H

o

or more) to

a

re examples

o

f Active Phar

m

y

to meet exp

e

d volume to

b

p

ublic health i

f

m

pliance of th

e

the tender d

o

Health reserv

e

a

ble for a 28-

d

f

actor will be

a

aluation. Simi

l

s

offered.

e

cial Conditi

o

P

ATION

e

asury Regula

t

m

s of the Pub

l

n

g Authority m

a

n any contrac

n

approval of

s

H

ealth reserv

e

H

ealth reserv

e

H

ealth reserv

e

a

ddress high

v

o

f considerati

o

m

aceuticaI In

g

e

cted demand

b

e supplied;

f

the item is n

o

e

bidder with

c

o

es not achiev

e

s the right n

o

d

ay treatment

a

pplied. Direct

larly, no conv

e

o

ns of Contr

a



t

ions for Dep

a

l

ic Finance M

a

y, on behalf

o

t arranged by

s

uch organ of

e

s the right to

e

s the right to

e

s the right to

v

olume requir

e

o

ns which ma

y

g

redient (API)

as per publis

h

o

t available;

c

ontractual ob

l

e the most ec

o

t to award th

a

cycle are req

u

comparisons

e

rsion factors

w

a

ct: HP06-2

0

a

rtments, Trad

a

nagement A

c

o

f a departme

means of a c

o

state and the

award contra

c

negotiate pric

e

award the sa

m

e

ments, secu

r

y

be taken int

o

and actual m

a

h

ed estimates

l

igations.

o

nomically ad

a

t item. In the

c

u

ired. Should

a

will be made

b

will be applie

d

0

21SVP

ing Entities,

C

c

t, 1999, (Act

1

nt, constitutio

n

o

mpetitive bid

d

relevant cont

r

c

ts to more th

a

e

s.

m

e item as a

m

r

ity of supply

a

o

account whe

a

nufacturing

s

in the Excel

B

vantageous p

c

ase of medic

a

30-day or ot

h

b

etween the

2

d

in cases wh

e

C

onstitutional

E

1

of 1999), st

a

n

al institution

o

d

ing process

b

r

acto

r

s.

a

n one contra

c

m

ultiple award

a

nd product a

v

n contemplati

n

s

ite;

B

id Response

rice, the Nati

o

ines for chron

h

er pack size

2

8-day and ot

h

e

re a pack siz

e

E

ntities and

a

tes that the

o

r public

b

y any organ

c

tor for the

to various

v

ailability.

n

g a multiple

Document;

o

nal

ic conditions,

be offered,

h

er pack

e

other than

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 71

Page 23

o

T

r

e

it

e

a

n

t

h

T

H

e

f

20.1

S

T

e

n

T



T

w

Catego

r

o

f 38

he National D

e

quired, due t

o

e

ms registere

d

n

d time of bid

h

e contract for

he Departme

n

H

owever, in ca

s

f

fect.

S

PLIT AND

M

he National D

n

sure securit

y

he following

w



Source

o



Capacit

y



Estimat

e



Risk to

p



Past co

m

w

o-way split

a

r

y

A

B

C

D

E

Sp

e

epartment of

H

o

emerging cli

n

d

in terms of t

h

closure. In th

e

an item, or a

d

n

t of Health wi

s

es where pa

t

M

ULTIPLE A

W

epartment of

H

y

of supply.

w

ill be taken in

o

f API and ma

y

to meet exp

e

d volume to

b

p

ublic health i

f

m

pliance of th

e

a

wards will be

e

cial Conditi

o

H

ealth may c

h

nical evidenc

e

h

e Medicines

e

se circumsta

n

d

just the quan

ll notify the c

o

t

ient safety is

a

W

ARDS

H

ealth reserv

e

to considerati

o

nufacturing si

t

e

cted demand

b

e supplied.

f

the item is n

o

e

bidder with

c

made in acc

o

Differ

e

o

ns of Contr

a



h

ange treatme

e

, disease pro

f

and Related

S

nces, the Nati

tity awarded

b

o

ntracted sup

p

a

concern, th

e

s the right to

o

n when cont

e

t

e.

as per publis

h

o

t available.

c

ontractual ob

l

o

rdance with t

h

e

nce betwee

n

scored

Equal points

< 5 points

>5-10 points

>10-20 point

s

>20 points

a

ct: HP06-2

0

nt protocols a

f

iles, safety o

r

S

ubstances A

c

onal Departm

e

b

ased on exp

e

p

lier within a r

e

se changes

m

issue split or

m

e

mplating a s

p

h

ed estimates

l

igations.

h

e following s

c

n

points

s

0

21SVP

nd/or product

r

resistance p

a

c

t, 1965, (Act

1

e

nt of Health

r

e

cted changes

e

asonable tim

e

m

ay be imple

m

ultiple awar

d

p

lit award:

in the Bid Re

s

c

hedule base

d

Recommen

d

formulations

w

a

tterns and av

a

1

01 of 1965)

a

r

eserves the r

i

in projected

d

e

of the expec

m

ented with im

d

s, where nec

e

s

ponse Docu

m

d

on the point

s

d

ed percent

a

50/50

60/40

70/30

80/20

90/10

w

here

a

ilability of

a

t the date

i

ght to cancel

d

emand.

ted change.

mediate

e

ssary, to

m

ent.

s

scored:

a

ge split

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 72

Page 24

o

20.2

T

d

t

c

a

t

f

T

S

m

f

c

m

w

S

a

o

f 38

Where a spli

t

volumes for

a

 For a th

r

 For a fo

u

T

HERAPEU

T

he Policy for

d

efines a ther

a

t

herapeutic ef

f

c

lass, may dif

f

a

ction, result i

t

hese medicin

f

or a specific i

n

T

he ministeri

a

S

tandard Tre

a

m

entioned in

t

f

ollowed by a

n

c

lasses have

b

m

ember of th

e

w

here approp

r

S

uch therape

u

a

dvantageou

s

o

ffering the o

p

A single me

m

Sp

e

t

for more tha

n

a

ward:

r

ee way split:

S

u

r way split: S

u

T

IC CLASS

A

Classifying

M

a

peutic class

a

f

ects. Medicin

e

f

er in chemist

r

n different ad

v

es have close

n

dication.

a

lly appointed

a

tment Guideli

t

he “Medicine

n

example su

c

b

een designa

t

e

class for a s

p

r

iate.

u

tic classes m

s

contract, off

e

p

portunity for

c

m

ber of the c

l

e

cial Conditi

o

n

2 suppliers i

s

S

upplier shar

e

u

pplier share

=

A

WARDS

M

edicines into

T

a

s a group of

e

s in a therap

e

r

y or pharmac

o

v

erse reaction

e

similarity in e

National Esse

nes (STGs) a

n

treatment” se

c

h as, HMGC

o

t

ed where no

n

p

ecific indicati

ay be used d

u

e

r the market t

c

ost efficienci

e

lass may be

a

o

ns of Contr

a



s

contemplat

e

= 33.3% + (

s

=

25% + (sup

p

T

herapetic Cl

a

medicines wh

e

utic class m

a

o

kinetic prop

e

s, have differ

e

fficacy and s

a

e

ntial Medicin

e

nd Essential

M

c

tion of the n

a

o

A reductase i

h

n

e of the mem

b

on. The NEM

L

u

ring the cont

r

he largest vol

u

e

s by stimulati

a

warded.

a

ct: HP06-2

0

e

d, the followi

n

s

upplier score

p

lier score -

m

a

sses for Pur

p

ich have activ

e

a

y or may not

e

rties, and ma

y

e

nt toxicity an

d

a

fety profiles,

w

e

s List Commi

t

M

edicines List

a

tional STGs

w

h

ibitors (Stati

n

b

ers of the cl

a

L

C will design

a

r

acting proces

s

u

me and incr

e

ng robust co

m

0

21SVP

n

g formula ma

y

- mean score

)

m

ean score) x

2

p

oses of Ther

a

e

ingredients

w

belong to the

s

y

possess diff

e

d

drug interac

t

w

hen adminis

t

tee (NEMLC)

(EML). Thera

w

hich provide

s

n

s) e.g. simav

a

ss offer any s

a

te therapeuti

s

to achieve t

h

e

ase the num

b

m

petition.

y

be used to

a

)

x 2.3%

2

%

a

peutic Interc

h

w

ith compara

b

s

ame pharma

e

rent mechan

i

t

ion profiles. I

n

t

ered in equip

o

formulates a

n

peutic classe

s

a class of m

e

a

statin. These

ignificant ben

e

c classes for

a

h

e most econ

o

b

er of competi

t

a

llocate

h

ange

b

le

cological

i

sms of

n

most cases,

o

tent doses

n

d revises the

s

are

e

dicines

therapeutic

e

fit over

a

condition,

o

mically

t

ors, thereby

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 73

Page 25

o

21

N

T

s

u

22.

N

T

p

r

I

n

r

e

23.

P

T

c

o



T

h

C

Seri

o

f 38

N

EGOTIATI

O

he National D

u

ccessful bid

d

N

ON-COMMI

T

he National D

he right is als

o

r

ior to closing

n

the event th

a

e

medy the ma

P

RICE REVI

E

he National D

o

ntract:

A

routine

a

A

n excepti

h

erapeutic

lass and

es Number

Class 1

Class 2

Sp

e

O

NS

epartment of

H

d

er(s) post aw

a

T

MENT

epartment of

H

o

reserved to

w

of the bid an

d

a

t an incorrect

tter in any ma

E

W

epartment of

H

a

djustment to

m

onal adjustm

e

Therapeuti

c

description

Surfactant -

g

Surfactant -

g

e

cial Conditi

o

H

ealth reserv

e

a

rd.

H

ealth reserv

e

w

ithdraw or a

m

d

post award

award has b

e

nner it may d

e

H

ealth envisa

g

m

itigate foreig

e

nt to mitigate

c

class

M

g

roup 1

P

V

N

1

g

roup 2

P

V

N

2

o

ns of Contr

a



e

s the right to

e

s the right no

m

end any of t

h

e

en made, the

e

em fit.

g

es three typ

e

n exchange fl

u

significant sh

o

M

embers of t

h

P

hospholipids,

V

s

N

atural Phosp

h

20mg in 1.5

m

P

hospholipids,

V

s

N

atural Phosp

h

2

40mg in 3ml,

a

ct: HP06-2

0

negotiate wit

h

t to award, to

h

e bid conditi

o

National Dep

a

e

s of price revi

uctuations;

o

rt-term foreig

h

e therapeuti

c

Total (Beract

a

h

olipids (Pora

c

m

l, 1.5ml

Total (Beract

a

h

olipids (Pora

c

3ml

0

21SVP

h

the bidders

p

award in part,

o

ns, by notice,

a

rtment of He

a

ew processe

s

n exchange fl

c

class

a

nt), 100mg/

4

c

tant alpha), i

n

a

nt), 200mg/

8

c

tant alpha), i

n

p

rior to award

a

or in full.

in writing to

a

lth reserves

t

s

for the durati

o

uctuations; a

n

4

ml, 1 Vial

n

tra-tracheal

s

8

ml, 1 Vial

n

tra-tracheal

s

a

nd with the

a

ll bidders

t

he right to

o

n of this

n

d

s

olution,

s

olution,

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 74

Page 26

o



23.1

E

T

A

23.1.1 I

N



23.2 P

O

p

r

A

o

f 38

A systema

t

E

LIGIBILITY

R

ligibility for pri

he submissio

n

A

ssessment of

N

STRUCTIO

N

The price b

version. Th

e



A

ctive

 Form

u

 Pack

a

 Logist

 Gross



The sum o



The local

+

(e.g. Porti

o

componen

t



VAT must



Labour m

u



Breakdow

n



The Natio

n

componen

t

RICE ADJUS

O

nly the portio

n

r

ice breakdo

w

A

djustments ar

Sp

e

t

ic review of p

RELATING

T

ce adjustmen

t

n

of a complet

the rationalit

y

N

S FOR PRIC

E

reakdown mu

e

delivered pri

Pharmaceuti

c

u

lation;

a

ging;

ics (this inclu

d

margin (rem

a

f these categ

o

+

imported po

r

o

n of API att

r

t

).

be apportione

u

st be apporti

o

n

must be in p

nal Departm

e

t

s of the bid p

r

TMENTS RE

L

n

of the bid pr

i

w

n on the sign

e

e always calc

u

e

cial Conditi

o

rices for com

p

T

O RATE O

F

t

s relating to f

o

e price break

d

y

of this price

b

E

BREAKDO

W

st be comple

t

ce must be di

v

c

al Ingredient

s

d

es transporta

t

a

ining portion)

.

o

ries must be

e

r

tions of the fi

r

ibutable to lo

c

d equally acr

o

ned appropri

a

ercentage for

m

e

nt of Health

r

ice, which m

a

L

ATING TO F

i

ce facing for

e

d bid submis

s

u

lated using t

h

o

ns of Contr

a



p

arable produ

c

F

EXCHANG

o

reign excha

n

d

own per instr

u

b

reakdown by

W

N

t

ed on the sig

v

ided across

f

s

(API);

tion, warehou

s

.

e

qual to 100

%

rst three com

p

cal + Portion

o

ss all compo

n

a

tely across th

m

at to the clo

s

reserves th

e

a

y include au

d

OREIGN EX

C

e

ign exchange

s

ion.

h

e original aw

a

ct: HP06-2

0

c

ts available i

n

E

A

DJUST

M

n

ge risk depen

uctions below

the National

D

ned bid resp

o

f

ive compone

n

s

ing and distri

%

of the delive

r

p

onents must

of API attrib

u

n

ents and not

e relevant co

m

s

est whole pe

r

e

right to en

g

d

it of invoices

a

C

HANGE RIS

K

risk will be a

d

a

rded contrac

t

0

21SVP

n

the internati

o

M

ENTS

ds on:

for all releva

n

D

epartment of

o

nse docume

n

ts

bution);

r

ed price for t

h

add up to 10

0

u

table to imp

o

regarded as

a

m

ponents.

r

centage (e.g.

g

age with bid

a

nd related d

o

K

d

justed. This

p

t

ed price as t

h

o

nal market pl

n

t products; a

n

Health.

n

t as well as

t

h

e line item.

0

% within ea

c

o

rt = 100% o

f

a

separate co

m

20%).

d

ders to verif

y

o

cumentation.

p

ortion is dete

r

h

e base.

ace.

n

d

t

he electronic

c

h component

f

specific API

m

ponent.

y

any of the

r

mined by the

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 75

Page 27

o

P

b

a

R

E

c

o

B

S

s

u

R

23.3

A

S

H

W

a

d

F

L

o

f 38

rice adjustme

n

a

se average r

R

ates are sour

c

ligibility for fa

v

o

mpliance wit

h

B

ase average

R

hould the bid

d

u

bmit the calc

R

eserve Bank

p

A

PPLICATIO

N

canned copie

s

H

ealth prior to

t

W

here no appli

d

justment wo

u

oreign excha

n

o

gistics.

Sp

e

n

ts relating to

ate of exchan

g

c

ed from the

R

v

ourable Cont

r

h

contractual

o

RoE for this

t

Curren

Rand per U

S

Rand per B

r

Rand per

R

and per Yuan

R

and per Indi

a

R

and per Dan

d

er make use

ulated averag

p

ublished rat

e

N

FOR CONT

R

s

of signed a

p

t

he submissio

n

cation for an

a

u

ld be favoura

n

ge adjustme

n

e

cial Conditi

o

foreign exch

a

g

e (RoE) and

R

eserve Bank

r

actual Price

A

o

bligations.

t

ender will b

e

cy

S

Dollar

r

Pound

Euro

Renminbi

a

n Rupee

ish Krone

of any curren

c

e RoE for the

e

s for the spe

c

R

ACTUAL PR

p

plications for

n dates detail

e

a

djustment rel

a

ble to the De

p

n

ts may never

o

ns of Contr

a



a

nge will be b

a

an adjustmen

(www.resban

k

A

djustments

m

e

as follows,

p

c

y not mentio

n

period 1 Jan

u

c

ific currency.

ICE ADJUST

M

price adjustm

e

d in the tabl

e

ating to foreig

p

artment, this

w

result in a pri

c

a

ct: HP06-2

0

a

sed on the p

e

t average Ro

E

k.co.za).

m

ay be withdr

a

p

er currency

:

Base Avera

g

the period

n

ed above, th

e

u

ary 2020 to 3

0

M

ENTS

e

nts must be

r

e

s below.

n exchange h

a

w

ill be imple

m

c

e exceeding

t

0

21SVP

e

rcentage cha

n

E

.

a

wn in light of

e

:

g

e Rates of E

x

1 January 20

16.61

20.9

0

18.3

0

2.34

0.22

2.43

e

bidder must

s

0

June 2020

u

r

eceived by th

e

a

s been recei

v

m

ented autom

a

t

he current Si

n

ge between

t

e

vidence of p

o

x

change Ave

r

20 to 30 Jun

e

0

s

tipulate this

c

u

sing the Sout

e

National De

v

ed and such

a

tically.

n

gle Exit Pric

e

t

he relevant

o

or

r

age for

e

2020

c

learly and

h African

partment of

an

e

, ex

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 76

Page 28

o

23.4

R

S

t

a

Revie

w

1

2

3

4

5

23.5 E

S

b

e

i

n

Revie

w

0.1

1.1

2.1

3.1

4.1

5.1

o

f 38

R

OUTINE PRI

C

chedules for

r

a

ble below:

w

P

e

ad

ju

01 Ma

y

01 Nov

e

01 Ma

y

01 Nov

e

01 Ma

y

XCEPTIONA

L

uppliers may

r

e

activated if

t

n

dicated in the

w

Perio

d

01

01 Nov

e

01

01 Nov

e

01

01 Nov

e

Sp

e

C

E ADJUST

M

r

outine price r

e

riod for ca

l

u

stment av

e

y 2021 - 31

O

e

mber 2021

-

y 2022 - 31

O

e

mber 2022

-

y 2023 - 31

O

L

PRICE ADJ

r

equest exce

p

t

he absolute c

h

table below f

l

d

for calcula

t

avera

ge

May 2021 -

e

mber 2021

-

May 2022 -

e

mber 2022

-

May 2023 -

e

mber 2023

-

e

cial Conditi

o

M

ENTS

e

views, and p

e

l

culatin

g

e

ra

g

e RoE

O

ctober 202

1

-

30 April 20

2

O

ctober 202

2

-

30 April 20

2

O

ctober 202

3

USTMENTS

p

tional price a

d

hange betwe

e

l

uctuates by

m

tin

g

ad

j

ust

m

e

RoE

31 July 202

1

-

31 January

31 July 202

2

-

31 January

31 July 202

3

-

31 January

o

ns of Contr

a



e

riods for calc

Su

b

requ

e

revie

w

o

1

03 N

o

2

2 03

2

03 N

o

2

3 03

3

03 N

o

d

justments ac

c

e

n the base R

o

m

ore than 10

%

m

ent

S

r

e

re

v

1

0

2022 0

3

2

0

2023 0

3

0

2024 0

3

a

ct: HP06-2

0

ulating adjust

m

b

mission of

e

st for proc

e

w

to reach t

h

o

ffice b

y

o

vember 202

May 2022

o

vember 202

May 2023

o

vember 202

c

ording to the

o

E and the th

r

%

.

S

ubmission

e

quest for p

r

v

iew to reac

h

office by

0

3 August 2

0

3

February 2

0

3 August 2

0

3

February 2

0

3 August 2

0

3

February 2

0

21SVP

m

ent average

e

h

e

D

a

ad

ju

b

e

2

1 01

0

2

2 01

0

2

3 01

schedule in t

h

r

ee month retr

o

of

r

oce

h

the

D

a

d

b

0

21 0

1

2

022

0

22 0

1

2

023

0

23 0

1

2

024

RoE are deta

a

te from wh

i

u

sted price

s

e

come effec

t

December

2

0

1 June 202

2

December

2

0

1 June 202

December

2

h

e table belo

w

o

spective ave

D

ate from

w

dj

usted pric

e

b

ecome effe

1

Septembe

r

01 March 2

0

1

Septembe

r

01 March 2

0

1

Septembe

r

01 March 2

0

iled in the

ich

s

will

t

ive

2

021

2

022

3

2

023

w

. These will

rage RoE

w

hich

e

s will

ctive

r

2021

0

22

r

2022

0

23

r

2023

0

24

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 77

Page 29

o

S

m

a

d

Revie

w

1

2

3

4

5

23.6 P

R

Th

co

m

W

h

wil

W

h

rig

24. Q

U

Pr

o

S

u

o

f 38

uppliers who

r

m

onths, rather

d

justment av

e

w

P

e

ad

ju

01 Aug

u

01 Fe

b

01 Aug

u

01 Fe

b

01 Aug

u

R

ICE ADJUS

T

e National De

m

parable glo

b

h

ere this revie

l enter into pri

h

ere the outc

o

ht to terminat

e

U

ALITY

o

ducts must c

u

bstances Act,

Sp

e

r

eceived exce

than the usua

e

rage RoE in t

h

e

riod for ca

l

u

stment av

e

u

st 2021 - 31

b

ruary 2022 -

u

st 2022 - 31

b

ruary 2023 -

u

st 2023 - 31

T

MENTS BAS

e

partment of H

b

al prices.

e

w identifies a

n

ce negotiatio

n

o

me of this ne

g

e

the award f

o

onform to the

1965 (Act 10

e

cial Conditi

o

ptional adjust

m

a

l six month hi

s

h

ese instance

l

culatin

g

e

ra

g

e RoE

October 20

2

30 April 20

2

October 20

2

30 April 20

2

October 20

2

ED ON A SY

S

ealth reserve

s

n

y prices that

a

n

s with the co

n

g

otiation is de

e

o

r the item in q

conditions of

1 of 1965) for

o

ns of Contr

a



m

ents will rec

e

s

torical avera

g

s are detailed

Submi

s

for p

r

reac

h

2

1 03 N

2

2 0

3

2

2 03 N

2

3 0

3

2

3 03 N

S

TEMATIC R

E

s

the right to r

e

a

re lower tha

n

tracted suppl

e

med unfavo

u

uestion.

registration of

the full durati

o

a

ct: HP06-2

0

e

ive routine a

d

g

e exchange

r

in the table b

e

s

sion of req

r

oce review

h

the office

ovember 20

2

3

May 2022

ovember 20

2

3

May 2023

ovember 20

2

E

VIEW

e

view internat

n

contract pric

e

ier.

u

rable, the Na

t

the product i

n

o

n of this cont

0

21SVP

d

justments ba

s

r

ate. The peri

o

e

low:

uest

to

b

y

D

a

ad

ju

b

e

2

1 01

0

2

2 01

0

2

3 01

ional prices t

o

e

s the Nation

a

t

ional Depart

m

n

terms of the

ract.

s

ed on the pr

e

o

ds for calcula

t

a

te from wh

i

u

sted price

s

e

come effec

t

December

2

0

1 June 202

2

December

2

0

1 June 202

December

2

o

identify lowe

s

a

l Department

m

ent of Health

Medicines an

d

e

ceding three

t

ing

ich

s

will

t

ive

2

021

2

022

3

2

023

s

t

of Health

reserves the

d

Bidder Signature:____________________________

HP06-2021SVP Page 78

Page 30

o

25. D

E

25.1 D

E

Fi

r

Tr

a

Th

co

n

th

e

Le

by

ca

l

Fa

22

25.2

Q

U

Th

qu

Pr

o

N

a

re

g

S

u

ali

g

o

f 38

E

LIVERY A

N

E

LIVERY B

A

r

m lead times

f

a

nsit and stor

a

e initial lead ti

n

tract and N

O

e

date of awa

r

ad time within

the Departm

e

l

endar days.

ilure to compl

y

of the Gener

a

U

ANTITIES

e quantities r

e

antity which

w

o

posed minim

a

tional Depart

m

g

arding MOQ

s

u

ppliers are re

q

g

ned with the

Sp

e

N

D QUANTI

T

A

SIS

f

or delivery m

u

a

ge condition

s

me as propo

s

O

T the date of

r

d.

the contract

p

e

nt, as confir

m

y

with the con

a

l Conditions

o

e

flected in the

w

ill be procure

d

um order qua

n

m

ent of Healt

h

s

cannot be re

q

uired to mai

n

needs of Part

e

cial Conditi

o

T

IES

u

st be quoted

s

applicable to

s

ed in the bid

r

placement of

t

p

eriod is defin

e

m

ed by the Pr

o

tractual lead t

o

f Contract.

bid are estim

a

d

during the c

o

ntities (MOQs

h

reserves the

ached, the bi

d

n

tain sufficient

icipating Auth

o

ns of Contr

a



for the durati

o

the relevant

p

r

esponse doc

u

t

he first order.

e

d as the tim

e

o

of of Delivery

ime will result

a

ted quantitie

s

o

ntract period

.

) should facili

t

right to negot

d

may not be

a

buffer stock t

o

rities.

a

ct: HP06-2

0

o

n of the cont

r

p

roducts must

u

ment will be

c

This period

m

e

from submis

s

document. T

h

in penalties b

s

and no guar

a

.

Fluctuations

t

ate delivery d

iate MOQs w

h

a

warded.

o

meet at lea

s

0

21SVP

r

act pe

r

iod.

be adhered t

o

c

alculated fro

m

ay not excee

d

s

ion of order t

o

h

is lead time

m

eing enforced

a

ntee is given

in monthly de

irectly to heal

t

h

ere necessa

r

s

t two-months

o

.

m

date of awa

r

d

75 calendar

o

supplier to t

i

m

ay not excee

d

as per parag

r

or implied as

mand may oc

c

t

h establishm

e

r

y. Where con

s

demand for a

l

r

d of the

days from

i

me of receipt

d

14

r

aph 21 and

to the actual

c

ur.

e

nts. The

s

ensus

l

l items,

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 79

Page 31

o

SECT

I

26.

S

U

26.1 S

u

th

e

co

n

N

a

Th

pe



o

f 38

I

ON C

U

PPLIER PE

u

pplier perfor

e

National De

p

n

tractor and t

h

a

tional Depart

m

e National De

rformance of

c

Complianc

e

A

s a minim

u

mechanism



A

ll tran

s



A

mont

 Produc

t

 Numbe

 Status

o

Attendance

 The N

a

not be

Suppli

e

efficien

The Partici

p

22 of the G

e

Non-compli

a

participatio

n

Sp

e

RFORMAN

C

r

mance mana

p

artment of H

e

h

e Participatin

m

ent of Healt

h

e

partment of H

c

ontracted su

p

e

with reportin

g

u

m, suppliers

defined by th

e

s

actional data

hly age analy

s

t

ion pipeline

d

r of units of th

o

f outstandin

g

of compulso

r

a

tional Depart

m

limited to, a

e

rs may be

cies in the su

p

ating Authori

t

e

neral Conditi

o

a

nce of cont

r

n

in future con

t

e

cial Conditi

o

C

E MANAG

E

gement will b

e

alth and, wh

e

g Authority, N

h

must be info

r

ealth, in colla

b

p

pliers in te

r

m

g

requirement

s

will be requir

e

National De

p

relating to or

d

s

is;

d

ata and forec

a

e item availa

b

e item in Qua

l

e item in the

c

g

orders.

r

y quarterly

m

ent of Healt

review of s

u

required to

p

ply chain to

b

t

ies shall imp

o

ns of Contra

c

r

acted suppli

e

t

racts.

o

ns of Contr

a



E

MENT

e the respons

e

re supplier p

e

ational Treas

u

r

med for corr

e

b

oration with t

s of this contr

a

s

according to

e

d to submit t

h

p

artment of H

e

d

ers;

a

st including:

b

le (stock on h

lity Assuranc

e

c

urrent month’

m

eetings

h will hold qu

u

pplier perfor

m

p

resent conti

b

enefit both s

u

o

se penalties,

c

t.

e

rs to the t

e

a

ct: HP06-2

0

ibility of Parti

c

e

rformance di

s

u

ry: Transver

s

e

ctive action.

he Participati

n

a

ct, including

o

reporting sch

h

e following in

e

alth:

and);

e

, awaiting rel

e

s production

p

arterly meeti

n

m

ance and f

o

nuous impro

v

u

ppliers and th

where deem

e

rms and co

n

0

21SVP

c

ipating Auth

o

s

putes cannot

s

al Contractin

g

n

g Authorities,

but not limite

d

edule and re

p

formation in

a

e

ase;

p

lan.

n

gs with suppl

o

recasted de

m

v

ement initia

t

e Departmen

t

e

d necessary

,

n

ditions of th

i

o

rities with ov

e

be resolved

b

g

Chief Direct

o

will monitor t

h

d

to the followi

n

p

orting mecha

n

a

specified for

m

iers which wil

m

and for the

t

ives aimed

t

of Health.

,

as per Para

g

is contract

m

e

rsight from

b

etween the

o

rate and

h

e

n

g:

n

ism.

m

at and via a

l include, but

next quarter.

at improving

g

raph 21 and

m

ay influence

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 80

Page 32

o



26.2

D



o

f 38

Contractors

order(s) as

w

Contractors

and deliver

y

The instruc

t

invoices m

u

orders issu

e

The Depart

m

quantity.

In order to

f

orders for t

h

Only orders

Suppliers

a

A

uthorities,

Changes to

The Partici

p

lead time s

p

to the sam

e

paragraph

2

In cases w

contracted

s

D

ELIVERY AD

Products

a

delivery in

s

The infor

m

requireme

n

Invoices

m

particular

m

Related S

u

Sp

e

should note

w

ell as for the

should note

t

y

points will b

e

t

ions appeari

n

u

st be strictly

e

d by the purc

m

ent of Healt

h

f

acilitate effici

e

h

e health esta

b

made using

a

re required

in a manner

s

any quantitie

s

p

ating Authori

t

p

ecified in the

e

quantity in

2

1.6 of the Ge

n

here an orde

s

upplier must

l

HERENCE

a

nd related d

o

s

tructions stip

u

m

ation on inv

o

n

ts as defined

m

ust reflect b

m

edicine, an

d

u

bstances Ac

t

e

cial Conditi

o

that each i

n

payment(s) t

h

t

hat the orde

r

e

specified by

t

n

g on the off

i

adhered to a

n

hasing institu

t

h

is under no

e

nt implemen

t

b

lishment as

p

a

n official, aut

h

to acknowle

d

s

tipulated by t

h

s

ordered ma

y

t

ies reserve t

h

contract and

m

substitution

o

neral Conditi

o

r is received

l

iaise with the

o

cumentation

u

lated on the

p

o

ices and do

c

by the Natio

n

oth the "pro

p

d

which is th

e

t

, 1965 (Act 1

o

ns of Contr

a



n

dividual pur

c

h

ereof.

r

(s) will be pl

a

t

he relevant p

i

cial order for

n

d under no

c

t

ions.

obligation to

t

ation of the d

p

er the purch

a

h

orised purch

a

d

ge receipt

o

h

e relevant P

a

y

only be mad

e

h

e right to ca

n

m

ay, at their d

o

f the goods

o

ns of Contrac

t

which appe

a

relevant Parti

must be del

i

p

urchase ord

e

c

uments relat

n

al Departmen

p

rietary name

e

name appr

o

01 of 1965),

a

ct: HP06-2

0

c

hasing instit

u

a

ced as and

w

urchasing ins

t

m regarding

t

c

ircumstance

s

accept any q

u

irect delivery

s

a

se order.

a

se order for

m

o

f all purcha

a

rticipating Au

t

e

upon receip

t

n

cel orders w

iscretion, pur

c

not supplied

t

).

a

rs to be irrat

cipating Auth

o

i

vered in acc

o

e

r.

ing to delive

r

t of Health.

"(brand na

m

o

ved in terms

a

nd the item

d

0

21SVP

u

tion is resp

o

w

hen required

t

itution(s).

t

he supply, d

i

s

should the

c

u

antity which

i

s

trategy, cont

r

m

at are valid.

se orders r

e

t

hority.

t

of an amend

e

here the lead

c

hase supplie

s

in conformity

ional or misa

o

rity prior to p

r

o

rdance with

r

y must com

p

m

e"/"trade na

m

of section 1

5

description a

s

o

nsible for g

e

during the c

o

i

spatch and

s

c

ontractor de

v

i

s in excess

o

r

acted suppli

e

ceived from

e

d purchase

o

time exceed

s

of a similar

q

with the co

n

a

ligned with e

r

ocessing the

o

the terms, c

o

p

ly with the

m

e") which is

5

(4) of the M

s

it appears i

n

e

nerating the

o

ntract period

s

ubmission of

v

iate from the

o

f the ordered

e

rs must pack

Participating

o

rder.

s

the delivery

q

uality and up

n

tract (as per

stimates, the

o

rder.

o

nditions and

m

inimum data

unique to a

M

edicines and

n

the contract

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 81

Page 33

o



26.3

C



o

f 38

circular a

n

replace th

e

Original in

delivery p

o

may not b

e

know whe

r

The suppli

storage, a

s

receipt by

t

Discrepan

c

supplier w

i

for the qu

a

Contracte

d

condition

a

may recou

C

ONTINUITY

O



Contracte

d



Contractor



Contractor

result in in

t

 regul

a

 any a

n

 indust

 challe

n

 any o

t



Contractor

as well as



Contractor

as well as

Sp

e

n

d Master Pr

o

e

MPC.

voices and

p

o

int. These do

e

the same a

s

r

e documents

i

er must ens

u

s

per product

t

he delegated

c

ies between

i

thin a reason

a

ntities receiv

e

d

suppliers wil

a

s formally ar

r

p any expens

e

O

F SUPPLY

d

suppliers m

u

s must maint

a

s must inform

t

errupted sup

p

a

tory action w

h

n

ticipated pro

b

rial action

n

ges with ma

n

t

her supply ch

a

s must direct

o

Participating

A

s must direct

Participating

A

e

cial Conditi

o

curement Ca

p

roof of deliv

e

cuments mus

t

s

the delivery

a

must be deliv

e

u

re that produ

t

's conditions

official.

invoice and p

a

ble time or

a

e

d to be chec

k

l be responsi

b

r

anged in con

s

e

s associated

u

st have at lea

a

in sufficient b

u

National De

p

ly, including

b

h

ich may impa

b

lems associa

t

n

ufacturing pi

p

a

llenges.

o

fficial comm

u

A

uthorities.

official comm

u

A

uthorities.

o

ns of Contr

a



talogue (MP

C

e

ry must be

a

t

be delivered

a

ddress stipu

l

e

red.

cts are deliv

e

of registratio

n

hysical stock,

a

s arranged w

k

ed upon recei

b

le for collecti

s

ultation with

t

with failure t

o

st two month

s

uffer stock thr

o

p

artment of H

e

b

ut not limited

ct on their G

M

t

ed with the a

v

p

eline;

u

nication relat

i

u

nication rela

t

a

ct: HP06-2

0

C

), or Master

a

uthorised by

to the author

l

ated on the

p

e

red in accor

d

n

. Delivery is

or damaged

ith the suppli

e

pt of delivery.

on of goods

d

t

he purchasin

o

collect such

g

s

' supply of th

e

o

ughout the d

e

alth at first k

n

to:

M

P status or t

h

v

ailability of a

c

i

ng to continui

t

ing to payme

n

0

21SVP

Health Prod

u

a delegated

ity responsibl

e

p

urchase orde

r

d

ance with th

e

deemed to t

e

stock, will be

e

r. This time

p

d

elivered erro

n

g authority. T

h

g

oods in acco

r

e

estimate at t

h

uration of the

n

owledge of a

h

at of entities

o

c

tive pharmac

ty of supply t

o

n

t challenges

u

ct List (MHP

L

official at th

e

for payment

r

. Suppliers a

r

e

appropriate

e

rminate upon

reported to t

h

p

eriod must m

a

n

eously, or in

h

e Participati

n

r

dance with th

h

e start of the

contract.

ny circumsta

n

o

n which they

eutical ingred

i

o

stockalert@

h

to medacc@

h

L

), which will

e

designated

. This may or

r

e required to

conditions of

signature of

h

e contracted

a

ke provision

the incorrect

n

g Authorities

h

e agreement

contract.

n

ces that may

are reliant;

i

ent (API);

h

ealth.gov.za,

h

ealth.gov.za,

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 82

Page 34

o



26.4

R

N

a

T

r

w

o

f 38



A

ll official

ensure co

n



It is the re

s

items. In t

h

source alt

e

not more

t

sourced fr

o



In the eve

n

Health res

e

duration o

f



Prior to t

h

submit th

e

4.The co

n

informatio

n



Name of t

h



The quanti



The perio

d



The altern

a



This provi

s

supply of t

h



Suppliers

m

the Gener

a



In terms o

f

Participati

n

urgently re

R

EPORTING

N

ational Dep

a

ssisted with

c

T

he National

r

equirements.

w

riting by the

Sp

e

communicati

o

n

tinuity of sup

p

s

ponsibility of

h

e event that

t

e

rnative prod

u

t

han three m

o

m another c

o

n

t that a cont

r

e

rves the righ

f

the contracte

h

e supply of

a

e

samples of

t

n

tracted supp

l

n

:

h

e product to

b

ties to be sup

p

d

for which th

e

a

tive product

m

s

ion is only a

p

h

e product.

m

ay be requir

e

a

l Conditions

o

f

the General

C

n

g Authorities

quired and is

a

rtment of H

e

c

omplying wit

h

Department

Any change

s

Directorate:

A

e

cial Conditi

o

n must inclu

d

p

ly.

the contracte

d

t

he contracte

d

u

ct of accepta

onths. In the

o

ntracted sup

p

r

acted suppli

e

t to proportio

n

d supplier’s i

n

a

n alternative

t

he product t

o

l

ier is also r

e

b

e supplied;

p

lied;and

e

product will

b

m

ust be suppl

p

plicable for

e

d to pay pen

a

o

f Contract P

a

C

onditions of

may purchas

e

not immediat

e

alth will pro

v

h

these requir

e

of Health m

s

to reporting

A

ffordable Me

d

o

ns of Contr

a



d

e detail of c

d

supplier to

e

d

supplier is u

ble quality an

case of a

m

p

lier for the sa

m

er

is unable t

o

n

ally reallocat

e

n

ability to sup

p

product can

b

o

be supplied

e

quired to f

u

b

e supplied.

ied at the cur

r

e

mergency s

u

alties for sup

p

a

ragraph 22.

Contract and

e

outside the

c

e

ly available.

v

ide the requi

r

e

ments.

ay, from tim

e

requirements

d

icines.

a

ct: HP06-2

0

orrective acti

o

e

nsure contin

u

nable to sup

p

d up to the s

a

m

ultiple award

m

e product.

o

supply in th

e

volumes to

a

p

ly.

b

e undertake

n

to the two h

e

u

rnish the D

e

r

ent price of th

u

pply and ca

n

p

ly exceeding

Special Requ

c

ontract in or

d

r

ements for r

e

to time an

or the reporti

0

21SVP

o

ns taken by

u

ous availabili

t

p

ly, the contra

c

a

me quantity

, the alternat

i

e

short term, t

a

n alternative

n

, the contra

c

e

alth establis

h

e

partment of

e contracted i

t

n

not be used

f

the contractu

a

irements and

d

er to meet its

e

porting and

d within rea

s

ng mechanis

m

the contract

e

t

y and supply

c

ted supplier

i

as required f

o

i

ve product s

h

he National

D

contracted s

u

c

ted supplier i

h

ments as list

Health with

t

em.

f

or routine an

a

l lead time a

s

Conditions of

s

requirement

s

successful bi

d

s

on, add to

t

m

will be co

m

e

d supplier to

of contracted

i

d required to

o

r a period of

hould not be

D

epartment of

u

pplier for the

s required to

ed in section

t

he following

d continuous

s

stipulated in

Contract, the

s

if the item is

d

ders will be

t

he reporting

m

municated in

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 83

Page 35

o

27.

P

27.1

P



o

f 38

P

ACKAGIN

G

P

ACKAGING



Suppliers

Packagin

g

Practice

a



Packagin

g

adversel

y



The pack

a

acceptab

l



The num

Docume

n



Where a

clearly ill

u



Where th

must be

a

 Oute

tamp

 The

c

whe

n

 Whe

r

be a

d

 Oute

tamp

 The

s

not a

 The

o

Sp

e

G

, LABELLI

N

must ensur

e

g

must be su

a

nd Good Dis

t

g

must be s

u

y

affect the sta

a

ging must b

e

l

e containers,

ber of units

n

t.

particular sta

c

u

strated on th

e

e contents of

a

dhered to:

r packaging

f

ering;.

c

ontents mus

t

n

opened.

r

e the conten

t

d

hered to:

r packaging

f

ering;.

s

hipper pack

llowed;.

o

uter packagi

n

e

cial Conditi

o

N

G AND BA

R

e

that produc

t

itable for furt

h

t

ribution Pract

i

u

itable for tra

n

bility and inte

g

e

uniform for t

h

specifically d

e

per shipper

p

c

king and sto

r

e

outer packa

g

the shipper

p

f

langes must

t

be packed i

n

t

s of a shippe

r

f

langes must

must contain

n

g must be cl

e

o

ns of Contr

a



R

CODES

t

s delivered

a

h

er dispatch,

s

i

ce.

n

sportation a

n

g

rity of the pr

o

h

e duration of

e

veloped for t

h

p

ack or origi

n

r

age configur

a

g

ing.

p

ack represen

be sealed wi

n

neat, unifor

m

r

pack repres

e

be sealed wi

only one pro

d

e

arly marked

a

ct: HP06-2

0

a

re received

s

torage and

s

n

d should pr

e

o

duct.

the contract

p

h

e product.

n

al carton m

u

a

tion is reco

m

t a standard

s

th suitable t

a

m

rows and

c

e

nt a non-sta

n

th suitable t

a

d

uct, mixing o

f

a

s a "Part Box

"

0

21SVP

in good orde

s

tacking acco

r

e

vent exposu

r

p

eriod. All pro

d

u

st be compl

e

m

mended by t

h

s

upply quanti

t

a

pe that will

c

olumns that

w

n

dard supply

q

a

pe that will

c

f

multiple pro

d

"

.

r at the poin

t

r

ding to Good

r

e to conditio

n

d

ucts must b

e

ted in the

B

h

e supplier, t

h

t

y of an item,

c

learly displa

y

w

ill facilitate

e

q

uantity, the f

o

c

learly displa

y

d

ucts in a sin

g

t of delivery.

Wholesaling

n

s that could

e

packaged in

B

id Response

h

is should be

the following

y

evidence of

e

asy counting

o

llowing must

y

evidence of

g

le shipper is

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 84

Page 36

o

27.

2

27

o

f 38

2

LABELLI



A

ll c

o

not l

e

 The

f

part

b

 I

o



R



N



B



E



S



B

 Whe

r

e.g.

t

indic

a

 Unit

p

in te

r

inclu

d

.3 BAR

C



A

ll

 Th

 Su

th

e



Sp

e

NG

o

ntainers, pac

k

e

ss than font

s

f

ollowing info

r

b

oxes:

tem name as

o

r Master He

a

R

egistered pr

o

N

umber of uni

B

atch number

E

xpiry date;

S

torage condi

t

B

arcode.

r

e the content

s

t

hermolabile,

h

a

ted on the o

u

p

acks must b

e

r

ms of the M

e

d

e a barcode

s

C

ODES

unit and ship

p

e European

A

ppliers are e

n

e

following inf

o

Item name

(MPC), or

M

The "propri

e

approved b

y

 Dosag

e

 Pack si

z

e

cial Conditi

o

k

aging and c

a

s

ize 48.

r

mation must

contained in

t

a

lth Products

L

o

duct name (i

f

ts in pack

;

t

ions;

s

of the shipp

e

h

igh-schedule

d

u

ter packagin

g

e

labelled in a

e

dicines and

s

uitable for th

e

p

er packs mu

s

A

rticle Number

i

n

couraged to

i

o

rmation:

as containe

d

M

aster Health

P

e

tary name

(

y

MCC or SA

H

e

form and str

e

z

e;

o

ns of Contr

a



a

rtons must b

e

be clearly an

d

t

he contract c

i

L

ist (MHPL),

w

f

applicable);

e

r pack requir

e

d

or cytotoxic

g

on a brightly

ccordance wi

t

Related Sub

s

e

identificatio

n

s

t be marked

w

i

ng Code 13 (

E

i

nclude a 2D

b

d

in the contr

P

roducts List

(

brand name

"

H

PRA;

e

ngth;

a

ct: HP06-2

0

e

clearly labell

e

d

indelibly pri

n

i

rcular and th

e

w

hich will repla

e

special atte

n

products, suc

coloured bac

k

t

h Regulation

s

tances Act, 1

n

and tracking

w

ith the appro

E

AN 13) has

b

arcode or si

m

act circular

a

(

MHPL) which

"

/"trade name

0

21SVP

e

d. Bulk pack

s

n

ted on all s

h

e

Master Proc

u

ce the MPC.

n

tion in terms

c

h instructions

k

ground.

10 of the Ge

n

965 (Act 101

of medication

priate barcod

e

b

een accepte

d

m

ilar on their

a

nd the Mast

e

will replace t

h

”) unique to

s

must be lab

e

h

ipper packs,

i

u

rement Cata

of storage an

d

must be clea

r

n

eral Regulati

o

of 1965). T

h

.

e

number and

d

as standard.

packaging th

a

e

r Procureme

h

e MPC.

a particular

e

lled in letters

i

ncluding any

logue (MPC),

d

/or handling,

r

ly and visibly

o

ns published

h

e label must

symbology.

a

t will include

nt Catalogue

medicine, as

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 85

Page 37

o

28



29.

C

E

W

h

a

c

su

c

W

h

su

b

o

f 38

SHELF LIF

E

Unless MCC

months upo

n

Contracted s

life provided

t



A

pplicat

i

replace

d



A

pplicat

i

 Upon n

o

cost; an

d

 Failure

t

disposal

If short-dat

e

will be appli

o A =

am

o

dis

c

Unless oth

e

with a shelf

-

E

DING, ME

R

h

ere a contra

c

ontract the c

o

c

h an event.

h

ere a contra

c

b

mit an officia

Sp

e

 Batch

n

 Expiry

d

E

or SAHPRA,

n

delivery.

uppliers may

a

that:

i

ons are acco

m

d

or credited b

e

i

ons are appr

o

tification of r

e

d

t

o collect the

of the produ

c

e

d products ar

e

ed for invoici

n

(12 – month

o

unt to be inv

o

c

ount formula.

e

rwise agreed

-

life of less th

a

R

GERS, TAK

c

ted supplier

p

o

ntracted sup

p

c

ted supplier

p

a

l request in w

r

e

cial Conditi

o

n

umber;

d

ate.

has approve

d

a

pply in writin

m

panied by a

n

e

fore or after

e

o

ved by the P

a

e

maining expi

r

products with

i

c

t by the Parti

c

e

delivered wi

n

g of short-dat

e

s to date of

e

o

iced is: Con

s

to, any Parti

c

a

n 12 months.

E OVERS A

N

p

lans to merg

e

p

lier must info

r

p

lans to cede

a

r

iting to the N

D

o

ns of Contr

a



d

a shorter s

h

g to Participa

t

n

undertaking

e

xpiry; and

a

rticipating Au

r

ed stock suc

h

i

n 30 days af

t

c

ipating Autho

r

thout the afor

e

d products:

e

xpiry) x 2%

x

s

ignment valu

e

c

ipating Auth

o

N

D CHANG

E

e

with, or is go

r

m the Nation

a

contrated ite

D

OH, three m

o

a

ct: HP06-2

0

h

elf life, prod

u

t

ing Authoritie

s

that such sh

o

thorities befo

r

h

products will

t

er written no

t

r

ity for the ac

c

e

mentioned u

n

x

consignme

n

e

minus A, w

h

o

rity may, wit

h

E

S IN SUPP

L

ing to be acq

u

a

l Department

m to another

s

o

nths prior to

t

0

21SVP

u

cts must hav

e

s

to supply a

p

o

rt-dated prod

r

e execution o

f

be collected

b

t

ification to th

e

c

ount of the s

u

n

dertaking th

e

n

t value short

h

ere A is the

v

h

out prejudice

,

L

IER DETAI

L

u

ired by, anot

h

of Health in

w

s

upplier, the

c

t

he proposed

e

a shelf-life

o

p

roduct with

a

ucts will be u

n

f

orders; and

b

y the supplie

e

supplier wil

l

u

pplier.

e

following dis

c

dated produ

c

v

alue of the o

u

,

decline to a

c

L

S

h

er entity or pl

a

w

riting at first

k

c

ontracted sup

effective date

.

o

f at least 12

a

shorter shelf

n

conditionally

r at their own

l

result in the

c

ount formula

c

t. Therefore,

u

tcome of the

c

cept product

a

ns to cede

k

nowledge of

plier must

.

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 86

Page 38

o

T

h

s

u

Th

un

t

Th

ad

30. CA

N

C

a

su

b

Th

un

t

31. THI

R

P

N

o

f 38

h

e NDOH res

e

u

pplier under t

e contracted

s

t

il such time t

h

e contracted

s

dress, name,

N

CELLATIO

N

a

ncellation of

b

mitted to the

e contracted

s

t

il such time t

h

RD PARTIES

articipating A

u

N

o third party i

s

Sp

e

rves the right

he prevailing

c

s

upplier is obli

h

at the NDOH

s

upplier must

i

or contact det

N

OF THE CO

N

a contract will

satisfaction o

s

upplier is obli

h

at the NDOH

u

thorities will

n

s

entitled to p

u

e

cial Conditi

o

to accept or

d

c

onditions of

c

ged to supply

has approve

d

inform the Na

t

ails and effec

t

N

TRACT

only be consi

f the Departm

ged to supply

has approve

d

n

ot make a pa

u

t an account

o

ns of Contr

a



d

ecline the re

q

c

ontract or to

c

the contracte

d

the request

t

ional Depart

m

t

these chang

e

i

dered after c

o

ent of Health.

the contracte

d

the request

t

yment to or c

o

f a Participat

END

a

ct: HP06-2

0

q

uest to cede

t

c

ancel the co

n

d

item under t

t

o cede the ite

m

ent of Health

e

s on the Cen

t

o

mpelling evid

e

d

item under t

t

o cancel the i

t

o

nsult with a t

h

ing Authority

o

0

21SVP

t

he contractu

a

n

tract.

he prevailain

g

m to another

s

at first knowl

e

t

ral Supplier

D

e

nce to supp

o

he prevailain

g

t

em.

h

ird party.

o

n hold.

a

l obligations t

o

g

conditions o

f

s

upplier.

e

dge of any c

h

D

atabase.

o

rt the reques

t

g

conditions o

f

o

the new

f

contract,

h

anges to

t

has been

f

contract,

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 87

ITEM LIST HP06-2021SVP

Item No Description

Therapeutic Class

Numbers

Unit Estimate

1 Acetylcysteine 200mg/ml, injection, 10ml Each 213,295

2 Adenosine 3mg/ml, injection, 2ml Each 74,740

3 Adrenaline (Epinephrine) 0.15mg/0.3ml, auto-injection, 0.3ml Each 5,570

4 Adrenaline (Epinephrine) 0.3mg/0.3ml, auto-injection, 0.3ml Each 2,336

5 Adrenaline (Epinephrine) 1mg/ml, injection, 1ml Each 7,520,710

6 Alfentanil 0.5mg/ml, injection, 2ml Each 119,310

7 Alprostadil 0.5mg/ml, injection, 1ml Each 6,250

8 Alteplase 50mg, 1 Vial Each 7,960

9 Aminophylline 25mg/ml, injection, 10ml Each 354,560

10 Amiodarone 50mg/ml, injection, 3ml Each 223,660

11 Atracurium 10mg/ml, injection, 2.5ml Each 81,270

12 Atracurium 10mg/ml, injection, 5ml Each 58,400

13 Atropine 0.5mg/ml, injection, 1ml Each 1,278,840

14 Atropine 1mg injection, 1ml Each 2,353,110

15 Betamethasone 4mg/ml, injection, 1ml Each 1,199,860

16 Biperiden 5mg, injection, 1ml Each 63,180

17 Bupivacaine 5mg, Adrenaline 5mcg/ml, injection, 20ml Each 292,780

18 Bupivacaine 5mg, Dextrose Anhydrous 72.7mg/ml, injection, 4ml Each 974,370

19 Bupivacaine 5mg/ml injection, spinal, 4ml Each 206,140

20 Bupivacaine 5mg/ml, injection, 10ml Each 971,660

21 Caffeine 20mg/ml, injection, 1ml Each 185,250

22 Calcium gluconate 10% m/v, injection, 10ml Each 754,340

23 Cisatracurium 2mg/ml, injection, 2.5 ml Each 266,650

24 Cisatracurium 2mg/ml, injection, 5ml Each 237,390

25 Clonazepam 1mg/ml, injection, 1ml Each 514,285

26 Clotiapine 10mg/ml, injection, 4ml Each 78,395

27 Dantrolene 20mg, injection, 70 ml Each 2,280

28 Desferrioxamine 500mg, injection Each 49,970

29 Desmopressin 4mcg, injection, 1ml Each 9,660

30 Dexamethasone 4mg, injection, 1ml Each 5,270,300

31 Dexmedetomidine, 100 mcg/ml, Injection for infusion, 2ml Each 58,320

32 Dextrose 50% m/v, injection, 20ml Each 1,293,980

33 Dextrose 50% m/v, injection, 50ml Each 1,140,740

34 Diazepam 5mg/ml, injection, 2ml Each 771,330

35 Diclofenac 25mg/ml, injection, 3ml Each 8,327,390

36 Digoxin 0,25mg/ml, injection, 2ml Each 39,280

37 Dinoprost 5mg, injection, 1ml Each 900

38 Dobutamine 12.5mg/ml, injection, 20ml Each 206,440

39 Dopamine 40mg/ml, injection, 5ml Each 106,755

40 Enoxaparin 40mg, injection, 0.4ml Each 8,663,680

41 Enoxaparin 60mg, injection, 0.6ml Each 901,800

42 Enoxaparin 80mg, injection, 0.8ml Each 2,019,230

43 Ephedrine 50mg, injection, 1ml Each 325,270

44 Ergometrine 0.5mg, injection, 1ml Each 24,700

45 Erythropoietin 10 000 iu, injection, 0.6ml Each 88,800

46 Erythropoietin 2 000 iu, injection, 0.3ml Each 320,510

47 Erythropoietin 30 000 iu, injection, 0.6ml Each 6,520

48 Erythropoietin 4 000 iu, injection, 0.3ml Each 683,630

Page 1 of 4

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 49

ITEM LIST HP06-2021SVP

Item No Description

Therapeutic Class

Numbers

Unit Estimate

49 Erythropoietin 6 000 iu, injection, 0.3ml Each 13,624

50 Etomidate 2mg/ml, injection, 10ml Each 145,080

51 Fentanyl 0.05mg/ml, injection, 2ml Each 1,581,570

52 Fentanyl 0.05mg/ml, injection, 10ml Each 370,850

53 Fluorescein 100mg/ml, injection, 5ml Each 1,536

54 Flupenthixol decanoate 20mg/ml, injection, 1ml Each 1,507,530

55 Furosemide 10mg/ml, injection, 25ml Each 245,280

56 Furosemide 10mg/ml, injection, 2ml Each 7,085,900

57 Furosemide 10mg/ml, injection, 5ml Each 342,230

58 Glucagon 1mg, injection, 1ml Each 30,050

59 Glyceryl trinitrate 1mg/ml, injection, 10ml Each 146,900

60 Glycopyrronium bromide 0.2mg/ml, injection, 2ml Each 622,200

61 Haloperidol 10mg/ml, injection, 2ml Each 24,220

62 Haloperidol 5mg/ml, injection, 1ml Each 447,790

63 Heparin 1000 iu/ml, injection, 5ml Each 693,310

64 Heparin 5000 iu/ml, injection, 5ml Each 946,240

65 Hydrocortisone 100mg/2ml, injection, 2ml Each 4,166,740

66 Hyoscine Butylbromide 20mg, injection, 1ml Each 2,338,110

67 Insulin analogue, Human, Long-acting, 100 u/ml, disposable pen, 3ml Each 33,860

68 Insulin analogue, Human, Ultrafast-acting 100 u/ml, disposable pen, 3ml Each 229,559

69 Insulin analogue, Human, Ultrafast-acting 100 u/ml, vial, 10ml Each 1,540

70 Insulin, Biosynthetic, Human, Isophane, 100 u/ml, disposable pen, 3ml Each 2,832,200

71 Insulin, Biosynthetic, Human, Isophane, 100 u/ml, vial, 10ml Each 903,640

72 Insulin, Biosynthetic, Human, Biphasic, 100 u/ml, soluble 30% and Isophane 70%, disposable pen, 3ml Each 11,488,740

73 Insulin, Biosynthetic, Human, Biphasic, 100 u/ml, soluble 30% and Isophane 70%, penfilll cartridge for use in

pens, 3ml

(PENS TO BE PROVIDED FREE OF CHARGE TO PATIENTS)

Each 2,188,000

74 Insulin, Biosynthetic, Human, Biphasic, 100 u/ml, soluble 30% and Isophane 70%, vial, 10ml Each 4,520,360

75 Insulin, Biosynthetic, Human, Soluble, 100 u/ml, disposable pen, 3ml Each 1,886,440

76 Insulin, Biosynthetic, Human, Soluble, 100 u/ml, vial, 10ml Each 387,840

77 Iron dextran containing elemental iron 50mg/ml, injection, 10ml Each 16,500

78 Iron dextran containing elemental iron 50mg/ml, injection, 2ml Each 211,350

79 Iron sucrose containing elemental iron 20mg/ml, injection, 5ml Each 271,550

80 Isulin analogue, Human, Ultrafast-acting 100 u/ml, penfill cartridge for use in pens, 3ml

(PENS TO BE PROVIDED FREE OF CHARGE TO PATIENTS)

Each 7,725

81 Ketamine 10mg/ml, injection, 20ml Each 96,930

82 Ketamine 100mg/ml, injection, 10ml Each 61,060

83 Ketamine 50mg/ml, injection, 10ml Each 87,050

84 Labetalol 5mg/ml, injection, 20ml Each 193,390

85 Lidocaine 1% m/v, injection, not for iv use, 20ml Each 1,821,100

86 Lidocaine 10% m/v, iv injection, 5ml Each 39,220

87 Lidocaine 2% m/v injection, not for iv use, 20ml Each 1,191,930

88 Lidocaine 2% m/v, Adrenaline 12.5mcg (1:80 000), dental cartridge, 1.8ml Each 18,119,370

89 Lidocaine 2% m/v, dental cartridge, 1.8ml Each 2,814,860

90 Lidocaine 2% m/v, iv injection, 5ml Each 1,964,420

91 Lorazepam 4mg, injection, 1ml Each 977,050

92 Magnesium sulfate 50%, injection, 2ml Each 5,111,040

93 Mannitol 25% m/v, injection, 50ml Each 19,320

94 Methylprednisolone 125mg, (as sodium succinate) injection, 2ml Each 33,765

Page 2 of 4

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 88

ITEM LIST HP06-2021SVP

Item No Description

Therapeutic Class

Numbers

Unit Estimate

95 Methylprednisolone 40mg, (as sodium succinate) injection, 1ml Each 5,160

96 Methylprednisolone 500mg, (as sodium succinate) injection, 8ml Each 100,830

97 Methylprednisolone acetate 40mg/ml, injection, 2ml Each 257,150

98 Methylprednisolone acetate 40mg/ml, injection, 5ml Each 18,412

99 Metoclopramide 5mg/ml, injection, 2ml Each 7,601,990

100 Midazolam 1mg/ml, injection, 5ml Each 595,200

101 Midazolam 5mg/ml, injection, 10ml Each 127,300

102 Midazolam 5mg/ml, injection, 3ml Each 948,930

103 Morphine 10mg/ml, injection, 1ml Each 3,307,110

104 Morphine 15mg/ml, injection, 1ml Each 1,772,750

105 Naloxone 0.02mg/ml, injection, 2ml Each 96,540

106 Naloxone 0.4mg/ml, injection, 1ml Each 504,980

107 Natural Phospholipids (Poractant alpha), intra-tracheal solution, 120mg in 1.5ml, 1.5ml Class 1 Each 35,215

108 Natural Phospholipids (Poractant alpha), intra-tracheal solution, 240mg in 3ml, 3ml Class 2 Each 17,274

109 Needle, Insulin, 31G x 5mm, sterile, suitable for use with all prefilled insulin injection devices, 100 Each 82,770

110 Needle, Insulin, 31G x 8mm, sterile, suitable for use with all prefilled insulin injection devices, 100 Each 377,460

111 Neostigmine 0.5mg, injection, 1ml Each 107,590

112 Neostigmine 2.5mg, injection, 1ml Each 481,450

113 Octreotide 0.05mg, injection, 1ml Each 14,020

114 Octreotide 0.1mg, injection, 1ml Each 119,395

115 Octreotide 0.2mg/ml, injection, 5ml Each 8,380

116 Oxytocin 10 iu, injection, 1ml Each 6,406,260

117 Oxytocin 5 iu, injection, 1ml Each 2,063,960

118 Oxytocin 5iu, Ergometrine 0.5mg, injection, 1ml Each 538,290

119 Pantoprazole 40mg, injection, 10ml Each 1,042,800

120 Paracetamol 10mg/ml, injection for IV infusion, 100ml Each 1,585,240

121 Paracetamol 10mg/ml, injection for IV infusion, 50ml Each 6,910

122 Pethidine 25mg/ml, injection, 1ml Each 354,260

123 Pethidine 50mg/ml, injection, 1ml Each 1,815,320

124 Pethidine 50mg/ml, injection, 2ml Each 2,769,710

125 Phenylephrine 10mg, injection, 1ml Each 637,460

126 Phenytoin 50mg/ml, injection, 5ml Each 1,278,200

127 Phospholipids, Total (Beractant), 100mg/4ml, 1 Vial Class 1 Each 35,215

128 Phospholipids, Total (Beractant), 200mg/8ml, 1 Vial Class 2 Each 17,274

129 Potassium Chloride 15%, m/v injection, 10ml Each 2,470,180

130 Potassium Phosphate Monobasic, Anhydrous, Potassium Phosphate Dibasic Anhydrous, 1.09g/1.05g,

injection, 10ml

Each 131,090

131 Promethazine 25mg/ml, injection, 1ml Each 691,430

132 Promethazine 25mg/ml, injection, 2ml Each 319,811

133 Propofol 10mg/ml, injection, 20ml Each 1,446,630

134 Propofol 10mg/ml, injection, 50ml Each 195,590

135 Protamine 10mg/ml, injection, 5ml Each 52,140

136 Quinine 300mg, injection, 1ml Each 46,610

137 Ranitidine 25mg/ml, injection, 2ml Each 822,410

138 Remifentanil 2mg, injection, 5ml Each 47,070

139 Rocuronium 50mg, injection, 5ml Each 777,100

140 Salbutamol 0.5mg, injection, 1ml Each 301,240

141 Sodium bicarbonate 4% m/v, injection, 50ml Each 109,550

Page 3 of 4

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 89

ITEM LIST HP06-2021SVP

Item No Description

Therapeutic Class

Numbers

Unit Estimate

142 Sodium bicarbonate 8.5% m/v, injection, 50ml Each 578,010

143 Sodium chloride 0.9% m/v, injection, 10ml Each 12,400,540

144 Somatropin 15iu, powder for injection, cartridge + diluent Each 23,720

145 Somatropin 30iu, powder for injection, cartridge + diluent Each 24,895

146 Somatropin 36iu, powder for injection, cartridge + diluent Each 426

147 Streptokinase 1.5MU injection Each 10,155

148 Suxamethonium 50mg/ml, injection, 2ml Each 635,010

149 Testosterone 1g injection, 1 injection Each 16,415

150 Thiopentone 0.5g, injection, 20ml Each 23,540

151 Tramadol 50mg/ml, injection, 2ml Each 3,207,480

152 Tranexamic Acid 100mg/ml, injection, 5ml Each 1,734,980

153 Vecuronium 4mg, injection, 2ml Each 53,840

154 Verapamil HCl 2.5mg/ml, injection, 2ml Each 17,910

155 Vitamin B Complex, injection, 10ml Each 429,600

156 Vitamin B1 (Thiamine) 100mg/ml, injection, 10ml Each 412,200

157 Vitamin B12 (Cyanocobalamin) 1000mcg, injection, 1ml Each 487,350

158 Vitamin K1 (Phytomenadione) 10mg/1ml, injection Each 773,990

159 Vitamin K1 (Phytomenadione) 2mg/0.2ml, injection Each 3,500,390

160 Water for injection BP, injection, 10ml Each 37,241,680

161 Water for injection BP, injection, 20ml Each 4,112,500

162 Zuclopenthixol acetate 50mg, injection, 1ml Each 228,680

163 Zuclopenthixol decanoate 200mg/ml, injection, 1ml Each 2,142,750

Page 4 of 4

2020/07/24

Bidder Signature:____________________________

HP06-2021SVP Page 90

Fill Online, Printable, Fillable, Blank INVITATIONTO BID (South Africa Department of Health) Form

Related forms

Fillable INVITATIONTO BID (South Africa Department of Health)

Fill Online, Printable, Fillable, Blank INVITATIONTO BID (South Africa Department of Health) Form

Related forms

First 20 documents completely FREE!